nct_id,brief_title,page_rank_score_brief_title,page_rank_score_brief_title_summary_combined
NCT01728181,A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation,0.0006603251774652495,0.0007630266897413274
NCT01731587,Anti-cancer MUC1-specific Immunotherapy for Unresectable Stage III Non-small Cell Lung Cancer,0.00058691612504157,0.0006593715032903857
NCT01710319,Mechanisms of Immunosurveillance for Lung Cancer,0.0008761522936284466,0.0005759363761077558
NCT01752101,Identification of a Plasma Proteomic Signature for Lung Cancer,0.0005097225305501428,0.00046461034941465125
NCT01752647,CT Screening For Lung Cancer in High Risk Patients: the Russian Study.,0.0007006468357077241,0.000543882406829416
NCT01788566,A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer,0.0005215855595449652,0.0005924909057641141
NCT01748981,"Fitness, Activity and Lung Cancer Study",0.0007549562371772945,0.0004334654434670216
NCT01770795,A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer,0.0006845367507050627,0.0006650515306500652
NCT01727076,"Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer",0.0007206712833482551,0.0007770272120755809
NCT01744925,Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFR,0.0008178394929069273,0.0009227320814460131
NCT01767974,Comparison of Sequencing and PNA Clamping of EGFR Gene in Patients With Non-Small Cell Type Lung Cancer,0.0006849253886691104,0.000565711088488566
NCT01755624,Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET),0.0007289255916217805,0.0006989394968844927
NCT01707888,VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer,0.0006032218583986474,0.0007803544657525909
NCT01741155,Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC),0.000665632860468691,0.0008001540874049603
NCT01741506,Coagulation Profile in Patients Undergoing Video Assisted Thorascopic Surgery (VATS) for Lung Cancer,0.0005636047301263832,0.0005121694944279867
NCT01737112,99mTc-3PRGD2 SPECT/CT in Lung Cancer Patients,0.0007052390578817688,0.0005790902343984473
NCT01737216,Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer,0.0006836965860341882,0.0006783488583543737
NCT01789892,Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer,0.000576958825418459,0.0005550378949065952
NCT01721759,Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens,0.0007999619372756973,0.0007051701064811311
NCT01749072,Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients,0.0006883353053707157,0.0006701050901770761
NCT01719068,Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos,0.00051085663366308,0.00041081451997440735
NCT01724801,Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer,0.0006756528720060448,0.0005153706494080836
NCT01743586,Respiratory Muscle Function Changes and Effects of Chest Physiotherapy Education Interventionin Advanced Lung Cancer,0.00045806361635628685,0.0004993119914039953
NCT01771796,Training Effects Following Resection Surgery in Patients With Lung Cancer,0.0006374931606784594,0.0005715669350593513
NCT01778920,Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA),0.0004262299400393687,0.0006452230355084973
NCT01708954,Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer,0.0007181224515673016,0.0008060235759425257
NCT01797913,The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer,0.0007365199582581268,0.0010326613175426762
NCT01799980,Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer,0.0006412800339355512,0.0005407494903658109
NCT01799395,Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer,0.0005855720833302357,0.0005028349306000505
NCT01720186,Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung Cancer,0.0004301636063166723,0.000486578126797178
NCT01720836,Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer,0.0006184603275202363,0.0006051507186087334
NCT01780181,Clinical Study of Chemotherapy Combined With Chinese Medicine on Survival Affect of Elderly Patients With Lung Cancer,0.0006424648510306929,0.0008213843325653548
NCT01772797,Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer,0.0010190178728322625,0.0009062698639033638
NCT01796288,The Value of Radiotherapy in the Oligometastatic Non-squamous Non-small Cell Lung Cancer With Clinical Benefits From Erlotinib as Second-line Treatment,0.0006212279585122397,0.0007139286155260372
NCT01763671,Paclitaxel-bevacizumab in Advanced Lung Cancer,0.0006140977509791697,0.0006025995428012258
NCT01793155,"Effects of Inspiratory Muscle Training After Lung Cancer Surgery, a Randomized Controlled Trial",0.00043954558727888205,0.00047939151638451123
NCT01705184,Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.,0.0004754256031445427,0.00042674055901822087
NCT01757158,Cesium-131 Seed Brachytherapy Plus Subtotal Resection for Lung Cancer Patients,0.0005673491105958622,0.0007387733387102364
NCT01781741,Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer,0.0007424012826624645,0.0007340710071462952
NCT01781988,Personalized Therapy in Non-small Cell Lung Cancer,0.0009470300251387546,0.0006304459295133771
NCT01714037,A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC],0.0007706113656270571,0.000789287167698462
NCT01786590,Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT),0.0006717569396055436,0.0005439148039856291
NCT01782287,Proteome-based Immunotherapy of Lung Cancer Brain Metastases,0.0006354924326855409,0.00045626890484078684
NCT01717482,Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer,0.0006170971046053842,0.0007284574002915863
NCT01745484,Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation,0.00046286860447477304,0.0006090036757223956
NCT02841228,Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer,0.0009521473775157775,0.0004829967586867105
NCT02895503,Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment,0.0007513602320423336,0.0008712117336641521
NCT02855281,Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer,0.0007099276351569033,0.0006232709920602019
NCT02877966,Evaluation of the Effects of a Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patients With Unresectable Advanced Non-small Cell Lung Cancer,0.0007253241137945419,0.0007330754936217027
NCT02817945,Dual Integrin αvβ3 and SSTR2 Targeting PET Imaging in Lung Cancer Patients,0.0006284171052602968,0.000607609379261912
NCT02844140,DE-CT in Lung Cancer Proton Therapy,0.0008772736118717449,0.0008501244645248513
NCT02879617,A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients,0.0007547850759412253,0.0006457856453513732
NCT02875340,A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer,0.0008522107509810182,0.0009374985217498692
NCT02804776,PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery,0.0004699607655579549,0.0005581147968933553
NCT02840227,The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resections,0.0005527653336997528,0.0005343366154511025
NCT02840578,NK Cell Activity in Smokers Screened for Lung Cancer,0.0007171914580867243,0.0004129383882618067
NCT02802540,"Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients",0.0005700994932321671,0.0005994389473487952
NCT02894853,Lung Cancer Early Molecular Assessment Trial,0.0006290060989378827,0.0005819553020632141
NCT02888743,Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer,0.0007087801375695727,0.0007315759795471623
NCT02887521,Pulmonary Rehabilitation Before Lung Cancer Resection,0.000628330636899904,0.0004515231392225218
NCT02869685,Clinical Research for the Consistency Analysis of PD-L1 in Lung Cancer Tissue and Plasma Exosome Before and After Radiotherapy,0.0004593091616322974,0.0004966244957701115
NCT02848872,Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer,0.0005698961237144251,0.0005951893508030672
NCT02803619,A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis,0.0007467038473287007,0.0007744072794808339
NCT02803333,Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study,0.0005427429127788403,0.0005432084043546499
NCT02803203,Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers,0.0005607934904476305,0.0006548466689162468
NCT02835690,"Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Pembrolizumab (MK-3475) in Chinese Participants With Non-Small-Cell Lung Cancer (MK-3475-032/KEYNOTE-032)",0.0007032707766283647,0.0009774503495345427
NCT02801409,Epidural Anesthesia/Analgesia and Outcome of Patients After Lung Cancer Surgery,0.0006326836220548303,0.0005771002606281341
NCT02801734,Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung Cancer,0.000632012604030573,0.0006171534705155491
NCT02846792,"Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer",0.0007278065425493608,0.0008178028615763198
NCT02846103,Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer,0.0006318086883255513,0.0006064810797602024
NCT02831959,Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS),0.0007121160731680521,0.0007103663645368569
NCT02827357,Responses to Chemotherapy of Patients With Non-small Cell Lung Cancer Harboring a Known Somatic Activating HER2 Mutation,0.0008119968469096965,0.0006164619323074851
NCT02827344,PDL-1 Expression on Circulating Tumor Cells in Non-small Cell Lung Cancer,0.0007146229732319036,0.0006269203874564668
NCT02898116,"A Study of ALK Inhibitor, Ensartinib, and Anti-PD-L1, Durvalumab, in Subjects With ALK-rearranged Non-small Cell Lung Cancer",0.0006424828564792931,0.0005832386673812481
NCT02839265,FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer,0.0006288569255913672,0.0006317300840343484
NCT02839629,Long-term Epidemiological Follow-up of Non-small Cell Lung Cancer in Scandinavia,0.001276530102597968,0.0009751595353142742
NCT02897765,"A Personalized Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer",0.0005721842550473471,0.0006866163990933131
NCT02821936,Parametric Imaging in Positron Emission Tomography for Patient With Lung Cancer,0.0006281325835409997,0.0006212152148073467
NCT02821949,Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy,0.0007068492728394526,0.0007804579358822163
NCT02845856,Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer,0.0006417842250548236,0.0008770161384094991
NCT02809456,"Mitigation of Radiation Pneumonitis, Fibrosis and Heart Toxicity With Nicorandil in Lung Cancer Patients",0.0005370146478140115,0.0005995361542243616
NCT02810457,Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer,0.0007835841016100076,0.0010417467626419872
NCT02810262,Association of Bone and Metabolic Parameters With Overall Survival in Patients With Bone Metastases From Adenocarcinoma Lung Cancer (POUMOS),0.0005336174218016022,0.00045932441944492676
NCT02873416,Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer,0.0007114010638304697,0.0005627651094274478
NCT02853006,Study on Fluids Associated to Lung Cancer,0.0007519803595354656,0.0004606646193676221
NCT02853188,Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung,0.0005131886300072182,0.0005796460740256285
NCT02856581,Smoking Cessation Prior to Surgery to Reduce Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes,0.0005724462060360916,0.0005373964701947334
NCT02822209,"Evaluation of the Impact of a Coordinating Nurse in a Personalized Care Program on Quality of Care, Coordination of the Actors and on Quality of Life for Patients With Lung Cancer",0.0005593080678842472,0.0005273918494242011
NCT02824458,A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations,0.0008092278540117116,0.0007880809375318869
NCT02823990,TG4010 and Nivolumab in Patients With Lung Cancer,0.0008884392590560682,0.0006816513569435387
NCT03101579,Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer,0.0007209813804876442,0.0006988290585078603
NCT01574300,Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network,0.0005489283867263233,0.0006444967348738295
NCT01579188,Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer,0.0007978316346160518,0.0008308348865305524
NCT01579994,Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers,0.000508943502049307,0.0005385459350874838
NCT01592617,Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer,0.0008078932399369493,0.0006763610058421618
NCT01580332,Non-Invasive Biomarkers For Early Detection Of Lung Cancers,0.0005226995710736789,0.000488188566676502
NCT01580735,ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer,0.0006625890029047971,0.0007182581855287299
NCT01580982,Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer,0.0005105866119937607,0.0004354249691923703
NCT01580579,Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With Chemoradiation,0.0005895035164435318,0.0004339773500319486
NCT01560104,A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer,0.0008176283008963238,0.000722714944571638
NCT01560195,A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy,0.0008229984685191907,0.0007003641543555036
NCT01577212,Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy,0.0007092140210019334,0.0007247905819905158
NCT01551251,Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer,0.0006917844722900203,0.0008184519471686947
NCT01537991,ISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START Trial,0.0007885131679178102,0.0009045302946383806
NCT01515969,Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC),0.0006653858750939183,0.0006993617343701308
NCT01585675,Specimen Banking From Patients With Lung Cancer,0.0008829965232480903,0.0004931582048443119
NCT01585883,Self-Management Intervention for Breathlessness in Lung Cancer,0.0005133549619851735,0.0006373234201963291
NCT01555502,Health Related Quality of Life After Video Assisted Thoracoscopic Lobectomy for Lung Cancer,0.0004148292019212257,0.0004573503532068297
NCT01507428,Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer,0.0007782390042606742,0.0007751019591358921
NCT01562015,A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC),0.0006679322990682133,0.0006526337931347156
NCT01578018,Tumor Markers in Lung Cancer: DCAMLK-1LK-1,0.0006549160289126075,0.00044896847435185863
NCT01546233,Multidisciplinary Education in Lung Cancer Patients Who Receiving Chemotherapy Treatment,0.0006782965249405925,0.0006905603286908436
NCT01540552,Natural History of Lung Nodules Seen on CT Scans From Participants at High-Risk of Developing Lung Cancer,0.0004581649298765663,0.0005835595876395938
NCT01529112,"A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments",0.0007007667087762561,0.0008021702918925694
NCT01565980,Mindfulness Therapy for Individuals With Lung Cancer,0.0006796080597640612,0.0006419392405614889
NCT01500876,A Feasibility Study Using Four-Dimensional CT Imaging for Primary Lung Cancer,0.0005129956476364742,0.0005232658998281555
NCT01593293,Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer,0.0007415357708309314,0.00065836297034597
NCT01527058,68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients,0.0007157340635224125,0.0005132223940285191
NCT01527461,Identifying Unique Scent Signature of Lung Cancer Through Body Odor,0.0006215298277402994,0.0005570542156558445
NCT01527864,Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer,0.0006500591969719266,0.0005723060346108762
NCT01576796,Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer,0.000598329994347103,0.000594881475036727
NCT01533233,Thoracoscopic Lobectomy Using Nonintubated Anesthesia Versus Intubated General Anesthesia for Lung Cancer Patients,0.0005479575124854791,0.0005873985129558135
NCT01581346,Exercise Study in Patients With Lung Cancer,0.0008055181326363625,0.0006285031782041274
NCT01556191,Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR,0.0006215163023112889,0.0006191480298700434
NCT01503385,Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC),0.0007644079218332796,0.0007845494883672905
NCT01539928,Dual PET/CT Imaging in Lung Cancer,0.0005234294048364036,0.00040914658587206884
NCT01532089,Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations,0.0007017909523042493,0.0007840383487336568
NCT01532362,Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer,0.0006984887464598743,0.0006318633358756594
NCT02237183,Iloprost in Preventing Lung Cancer in Former Smokers,0.000628345600408005,0.0005140265486476084
NCT02202655,Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer,0.0007752243124231307,0.0009149257808440967
NCT02223611,Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection,0.0005950189627946252,0.0007740529668071934
NCT02299505,Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC),0.0007688871611195671,0.0007044176571260051
NCT02221739,Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC),0.0006819129915554395,0.0007607973416880363
NCT02274025,NovellusDx Functional Profiling of Oncogenic Mutations in Lung Cancer Patients,0.0007061081625231328,0.00043972694920198105
NCT02271581,Effect of Symptom Management on Inflammation and Survival in Metastatic Lung Cancer,0.0005345178686145399,0.0004821403906763567
NCT02209727,Single Dose Escalation Study of 131I-Sibrotuzumab in Patients With Advanced or Metastatic Non-small Cell Lung Cancer,0.0008230308682599057,0.0008082400752030412
NCT02222194,The Value of Surgical Mediastinal Staging in Clinical N1 Lung Cancer,0.0004759277634190472,0.0004886042598936124
NCT02272127,Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer,0.0006457085352569592,0.000676295900254806
NCT02272413,Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer,0.0007402905776034327,0.0006747914055840162
NCT02215356,Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer,0.0007805924547086127,0.000731418157503535
NCT02204059,Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Non-small Cell Lung Cancer,0.000788335233325245,0.0008251576266356629
NCT02204345,A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology,0.0007190018716504666,0.0006806319588126696
NCT02276027,"A Phase II, Open Label, Multiple Arm Study of AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung Cancer",0.0008048028971037345,0.0008955149040869294
NCT02243748,Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers,0.0006743152272617414,0.0006445362719467787
NCT02206334,"Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer",0.0007172803261505216,0.000708518583709193
NCT02262325,Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery,0.0007370200568246081,0.0008789768410121799
NCT02211833,Dose Escalation Study of BI 2536 With Pemetrexed in Previously Treated Patients With Non-small-cell Lung Cancer,0.0008159440397487093,0.000979535674462486
NCT02297425,A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer,0.0008071289014606253,0.0005680927474752485
NCT02201992,Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial),0.000743263122614914,0.0008018299279807405
NCT02296125,AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer,0.0007694389203602526,0.0006658312157306146
NCT02220894,Study of MK-3475 (Pembrolizumab) Versus Platinum-based Chemotherapy for Participants With PD-L1-positive Advanced or Metastatic Non-small Cell Lung Cancer (MK-3475-042/KEYNOTE-042),0.0006946163723500664,0.0007943938110563374
NCT02277457,"Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations",0.0006531291886147273,0.0006373142913389122
NCT02250326,"Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer",0.0007101413281472161,0.0008121544383270627
NCT02250378,Stereotactic Radiosurgery Followed by Wedge Resection in Treating Patients With Early Stage Peripheral Non-small Cell Lung Cancer,0.0007425199977787564,0.0007388315791248498
NCT02245100,Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer,0.0007100622863367757,0.0008381741723395118
NCT02273336,Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer,0.0007130817373864832,0.0007587403882316679
NCT02208843,Afatinib as Second-line Therapy for Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation,0.0006839755916773404,0.0006056751633617828
NCT02231164,LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research,0.0006357661330291856,0.0005409213714469428
NCT02292550,Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.,0.0007932870194728482,0.0008652189278603289
NCT02284633,Blood Sample Monitoring of Patients With EGFR Mutated Lung Cancer,0.0007056293429491913,0.0006828848325663771
NCT02288026,Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer,0.000760165240541686,0.0009901777418096058
NCT00590902,"Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer",0.0006425037854042627,0.0007204711734682931
NCT00532155,A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer,0.0008050080634965535,0.0008071656872933119
NCT00570401,Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib,0.0006426679623989537,0.0006361159311361625
NCT00531076,Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer,0.0006489264244934354,0.000662552375191614
NCT00516022,"Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.",0.0006764520888376484,0.0007755624708733658
NCT00563420,Early Lung Cancer Detection in Patients With Sputum Cytology and Autofluorescence Bronchoscopy in People at High Risk of Lung Cancer,0.0005527970947759935,0.0005136510122324948
NCT00563160,Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery,0.0005312368813466801,0.0005384968924587293
NCT00517790,Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC),0.0007936819137142207,0.001105082543765352
NCT00540280,Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer,0.0005834548054666448,0.0007190285235702865
NCT00545948,Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer,0.0005793496523580957,0.0008741696223792607
NCT00547105,Erlotinib and Stereotactic Body Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Non-Small Call Lung Cancer,0.0006308955580774527,0.0005785531948029057
NCT00509457,GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC),0.0008145138926348902,0.0005500215469951471
NCT00596310,"Early Detection of Lung Cancer in a High-Risk Population Defined by PFT, Biomarkers, and CT Scanning",0.0004239124731592452,0.0005599204990884946
NCT00569114,Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients,0.0008787154489773027,0.0009436396452364734
NCT00569712,Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol,0.0005457416712506715,0.0004433386025686615
NCT00586937,Quality of Life in Lung Cancer Survivors,0.0008833557717566808,0.00045969436158650414
NCT00553800,Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer,0.0008236046023274349,0.0009825703078469364
NCT00553254,Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer,0.0009873144536308193,0.0014059634849496302
NCT00559065,A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China,0.0004975062279830727,0.0005684264356438729
NCT00582348,Physical Activity and Inactivity in Lung Cancer Survivors,0.0006301269862051191,0.0005962407421287731
NCT00508144,Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer,0.0005710673206525096,0.0005953582143793723
NCT00556647,Fast-track Diagnosis for Lung Cancer Suspects With PET-CT and EUS,0.0005279429988763953,0.0006919395422916965
NCT00522938,Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer,0.0007510629070845294,0.0008408851766052839
NCT00522639,Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation,0.0005978614895408,0.0006378562932191893
NCT00522197,ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia,0.0006279761362675747,0.00047083574275193945
NCT00578084,Lung Cancer Location: a Repository,0.0008761522936284458,0.0004471566558515146
NCT00519805,Dalteparin in Preventing Blood Clots in Patients With Lung Cancer,0.0007038542844005694,0.0005593966893951776
NCT00585377,"Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer",0.0006212804808050142,0.0006383468024429844
NCT00588835,Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients,0.0006433698186292769,0.0007150697661271947
NCT00530621,Study of Enzastaurin Versus Placebo With Pemetrexed for Patients With Advanced or Metastatic Lung Cancer,0.0006800793058459688,0.0007228759854496751
NCT00597636,Genetic Susceptibility to Lung Cancer in Never Smokers,0.0005155223722523828,0.00045044934988814174
NCT00506467,Vibration Response Imaging (VRI) in Lung Cancer Patients,0.0008818744681116138,0.0005082900023502841
NCT00568282,Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients,0.0006174228481194005,0.0008172524868693543
NCT00568490,Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers,0.0005585453765624443,0.0005710861498659655
NCT00579215,Lung Cancer Informational Study (LCIS),0.0006051946648928595,0.0005823237828551949
NCT00579462,Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer,0.0005272605244444947,0.000628398193422639
NCT00579683,Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer,0.0006864984952096019,0.0006042509679640067
NCT00512642,Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients,0.0005399255469414293,0.0006406754106874886
NCT00527982,Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer,0.0006149450167763247,0.0005219735051475162
NCT00504374,Gene Polymorphisms and Symptoms in Lung Cancer Patients,0.0008848340079899504,0.0006487291041144356
NCT00503958,Liverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung Cancer,0.0005633340654327987,0.0005539919299097078
NCT00583830,A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer,0.0006538960749144646,0.0008261069741281671
NCT00514215,Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer,0.0006143894241439142,0.0005741126757160533
NCT00538681,"Study for Patients With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + Placebo",0.0007226576914633902,0.0007386875019182787
NCT00576914,Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer,0.0007007929870657696,0.0006975245230417986
NCT02786589,Plasmodium Immunotherapy for Lung Cancer,0.0006263095221344122,0.0006719541536070796
NCT02715102,Circulating Tumor DNA in Patients at High Risk for Lung Cancer,0.000721113143669979,0.0005541916670811262
NCT02731001,Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer,0.00046631347793543357,0.000534508938230979
NCT02710565,Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma,0.0005163530175031804,0.000332256495773741
NCT02743923,Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer,0.0006374245731598726,0.0007353203406251004
NCT02734524,A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer,0.000630187637160161,0.0007553564048568159
NCT02713867,"A Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks",0.0006194521103508067,0.0007156906848046966
NCT02701699,18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer,0.0008761522936284458,0.0006946723281713762
NCT02701231,Low-frequency Rotating Magnetic System Combined With Systemic Anti-tumor Therapy for Advanced Lung Cancer,0.000523218220370668,0.0009089551522951605
NCT02740894,Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?,0.0005725478017403452,0.0006339467922903126
NCT02754882,A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer,0.0008469220924143115,0.0008566581483119394
NCT02754388,Early Detection of Lung Cancer With Low-dose Multislice Computed Tomography,0.0005119463480397697,0.00043622638448440585
NCT02716051,Wholebody MRI In Lung Cancer StagiNg,0.0016733468092925384,0.000491813441485511
NCT02716311,Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer,0.0006392498272706635,0.0007086101315940439
NCT02736643,Retrospective Epidemiological Study of Lung Cancer With Low-dose Multislice Computed Tomography,0.000607997367656315,0.0004572574844826622
NCT02789345,A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer,0.0006069312335532816,0.0008994291303582267
NCT02758678,Analysis of P-Selectin Expression on Platelets of Blood From Lung Cancer Patients,0.0005720400788187956,0.0005103602584628747
NCT02732834,Doctor-Patient Communication in Lung Cancer Care,0.0012673148055064591,0.0006991626979186334
NCT02781857,Mass Spectral Fingerprinting in Lung Cancer,0.0008761522936284458,0.0005352377806795412
NCT02720614,Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer,0.0008085330603955535,0.0008510809641465321
NCT02730247,Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0007616843548178103,0.0007720439154693269
NCT02771470,Intestinal Microflora in Lung Cancer After Chemotherapy,0.0006652281563831143,0.000599762672052644
NCT02771756,The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy,0.0006430639234070246,0.0007450237411340282
NCT02726633,Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer,0.000533126362852255,0.0009077398905528403
NCT02705404,A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing,0.0004612478363307817,0.00041456406533307535
NCT02705339,Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC),0.0007470590067483629,0.0005737551009506407
NCT02780778,Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer,0.0007628909143001339,0.000860173835185877
NCT02733107,The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer,0.0006836546781317629,0.0005733698775487409
NCT02708667,An Observational Research Of Crizotinib's Hepatic Toxicity In Non-small Cell Lung Cancer Patients,0.0006867044865593156,0.0006541885140228446
NCT02777788,Curative Study of Chinese Traditional Medicine to Treat Lung Cancer,0.0007538323389335178,0.0008777131322985249
NCT02773238,FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging,0.0007256532489271582,0.0007976702278378852
NCT02737774,Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation,0.0008216691251910787,0.0010264279674402604
NCT02751385,Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer,0.0006888777171873322,0.0005836618796016212
NCT02770014,Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer,0.00046647270821153613,0.0006664895026844819
NCT02718651,Blood-based Identification and Monitoring of Patients With ALK-translocated Lung Cancer,0.0006188401156519524,0.0007599909394729833
NCT02793856,PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer,0.0007390195367065595,0.0009591402607676829
NCT02764606,CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer,0.0007211457513056774,0.0006612432532978112
NCT02764866,Sleep Apnea in Lung Cancer: A Prospective Study,0.000751234977559124,0.0007852789757544357
NCT02764086,INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer,0.001070811655088184,0.0006224866989179528
NCT02755454,Perfusion CT Imaging in Lung Cancer With SBRT,0.0006303152999591915,0.0006038046699050556
NCT02755675,"uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung",0.0006946268458032403,0.000701301141358204
NCT02755337,The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase,0.0006276947806611598,0.0006773328083306908
NCT02755883,Strides for Life I: Increasing Physical Activity in Stage 1 Lung Cancer Patients,0.000619519663332727,0.0004942303885691758
NCT02775435,A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407),0.0006622446532338198,0.0007535039813766262
NCT02759679,Canine-Assisted Profiling of Lung Cancer From Human Breath,0.0006238099958522158,0.0005439238132136893
NCT02738593,Detection Cell Free DNA in Lung Cancer Patients,0.0009128953232406447,0.0005911333261397817
NCT02738684,A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test,0.0005391367361915498,0.0005504167461264557
NCT02745002,Navigated EBUS and Functional Imaging in Lung Cancer,0.0008761522936284458,0.00041021097571271304
NCT03070626,Preoperative Loading With Carbohydrates in Lung Cancer Surgery,0.0006520053723706392,0.0005009794812968308
NCT03091491,Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer,0.0006631667303893963,0.0006691243119061129
NCT03091816,"Dynamic Perfusion Computed Tomography Changes Before, During, and After Stereotactic Body Radiation Therapy in Patients With Localized Non-small Cell Lung Cancer",0.0006885964346256782,0.0006955630898901349
NCT03014648,Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC),0.0007118336551476083,0.000499925936001177
NCT03084692,Therapeutic Yoga and Resistance Exercise for Lung Cancer,0.0004903835785330535,0.0005036256206398562
NCT03089125,Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer,0.0006799919776926336,0.0009276146367299684
NCT03077854,Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial,0.00043506464924738684,0.0004987868431861859
NCT03092739,A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens,0.0005345309039285382,0.000756267857365823
NCT03092986,Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer,0.0006591225309740722,0.0006455468597811265
NCT03087708,Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer,0.0008109323651827589,0.0007679534017110686
NCT03048500,Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery,0.0006982089349743503,0.0007744297406543276
NCT03048136,A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer,0.0006862458204070231,0.0007600252277094787
NCT03048760,Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer Patients,0.0006140826852989428,0.0006471788527454414
NCT03053804,"Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction",0.0005874275050310025,0.0007114714063435111
NCT03053856,Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients,0.0007892324874910452,0.0009066883864494057
NCT03006575,Study of Consolidation Chemotherapy For Locoregional Recurrence Of Non-small Cell Lung Cancer After Surgical Resection,0.0006330950925874714,0.0006975881916465154
NCT03007953,Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II,0.0005177430490597241,0.0005238196648021089
NCT03007875,High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer,0.0005785085895786799,0.0008048135976830213
NCT03088930,Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer,0.0007191810248100484,0.0007582869979083156
NCT03081741,Circulating Tumor DNA in Surgical Lung Cancer Patients,0.0007414725329986846,0.0011432076106407502
NCT03029871,Oncolytic Adenovirus-Mediated Gene Therapy for Lung Cancer,0.0005055743008225834,0.0005790748796621562
NCT03029325,Molecular and Genetic Analysis of Lung Cancer,0.0006233704241860577,0.0005691359472912069
NCT03054038,Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer,0.0007437474333755629,0.0007762087121336635
NCT03017885,Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy,0.0007384027391224013,0.0005548844049596321
NCT03017183,Detection of Heterogeneity in Central Lung Cancer - EBUS-TBNA and ctDNA Analysis vs. Endobronchial Forceps Biopsy,0.0004250215722137618,0.0005440588686565071
NCT03095612,Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC),0.0006576503398680759,0.0007718023004466374
NCT03068663,Microbiota and the Lung Cancer,0.0016733468092925384,0.0006149339418040699
NCT03003468,Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Chemotherapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017,0.0005787332621799427,0.0005732395316456421
NCT03003962,A Study of Durvalumab Versus Standard of Care in Advanced Non Small-Cell Lung Cancer,0.0007000076255922193,0.0006848739986405357
NCT03010033,Effect of Pulmonary Rehabilitation on Perioperative Outcomes in Smoker Patients With Lung Cancer,0.0007118207725472215,0.000547030499441413
NCT03010657,Evaluation of a Food Intake Modification for Lung Cancer Patients,0.0006244442401525963,0.0009005340654275071
NCT03086733,Phase II Lung Metcore - Preoperative Metformin for Lung Cancer,0.0006289562872974857,0.00047105824169860536
NCT03047616,A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer,0.0005500758340163254,0.0006651536547538225
NCT03057340,The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells,0.0006297430228168114,0.0005634048463569295
NCT03090737,Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer,0.0007204057989512488,0.0010022455116380257
NCT03090880,Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE),0.0005147635845811378,0.0004377960452664277
NCT03030131,Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer,0.0006433437702014031,0.0007418309581399217
NCT03073902,The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.,0.0005763671084012931,0.0005765786210585567
NCT03083691,BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer,0.000463310087853272,0.0005988348464724861
NCT03099577,PET/CT-directed Hyperfractionated Radiation Dose Escalation in Stage III Non-small Cell Lung Cancer,0.0005851226158073251,0.0007433241689293839
NCT03009630,ENB Guided RFA for Early-stage Peripheral Lung Cancer,0.0006739977211565135,0.0007330002172524565
NCT03020251,Effects of Preoperative Rehabilitation in Patients Resected for Lung Cancer,0.0007081800737253216,0.0005430490084355287
NCT03082300,A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations,0.0007315243851804521,0.0007246985870403444
NCT03065764,89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer,0.0008877305802244182,0.0004564247154861404
NCT00256789,Once Weekly Radiation for Lung Cancer With Chemotherapy,0.0007160599773214835,0.0008701757999810295
NCT00255489,A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer,0.000670311983826439,0.0007801754008220802
NCT00255775,Broccoli Sprout Extract in Preventing Lung Cancer in Smokers,0.0005111591512815888,0.0003519233110425213
NCT00243867,Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer,0.0005669366585440308,0.0006237100581076558
NCT00250848,Lung Cancer Case Registry and Tissue Resource,0.0005135244003604972,0.0005079655648985968
NCT00219297,Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer,0.0007935897985261757,0.0008368186004629266
NCT00251589,A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025),0.000700115608200322,0.0007428867586812097
NCT00265200,Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer,0.0004605121797777206,0.000640651374121522
NCT00264602,Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer,0.0005086124461400914,0.0005158569112782509
NCT00281125,Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer,0.0006571071109885251,0.0005553524513742947
NCT00221169,Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer,0.0004924664795900508,0.0006559367469837874
NCT00280202,Detection of Genetic Markers of Lung Cancer,0.0005271452153867186,0.00040470978980304724
NCT00214123,Hypofractionated Radiotherapy for Lung Cancer,0.0008778252857390229,0.00044222680949040943
NCT00263731,Metabolomic Analysis of Lung Cancer,0.0016733468092925384,0.0011193897890692983
NCT00218179,Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1,0.0005190995157856232,0.0004945109580805073
NCT00260871,Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications,0.0005406007179204562,0.0004690439142947618
NCT00260598,LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer,0.000710974996765246,0.000695963611139159
NCT00294190,Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer,0.0007754220911060693,0.0006924386407084789
NCT00294736,A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens,0.0007573404975827687,0.0007458315768927044
NCT00246727,Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer,0.0009939789219865717,0.0007339547306254346
NCT00269828,A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.,0.0006250658297965677,0.0006712739462523012
NCT00277329,Study of XL999 in Patients With Non-small Cell Lung Cancer,0.001006483715305589,0.0007569614855792098
NCT00210080,A Study to Diagnose Lung Cancer by Sputum Cytology (01-312),0.0006162607767942097,0.0005880188142282331
NCT00273494,Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2,0.0006346688181389961,0.0008315569051593685
NCT00268970,Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer,0.000784824052466334,0.0009486171848083715
NCT00290550,A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006),0.0010123534044765104,0.0010881547868419464
NCT00290355,Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery,0.0005074949552469747,0.000733707947238485
NCT00226577,Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.,0.0006553553840252283,0.0007146937112743129
NCT00238602,Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer,0.0004618687867671749,0.0005111375259663845
NCT00238875,A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403),0.0008646729593395253,0.0012051217003761396
NCT00266812,Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED),0.0007565213947090143,0.00075282626822758
NCT00270582,A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer,0.00070421549357626,0.0007956026201954442
NCT00298415,Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC),0.0008385872162326975,0.0007761382838073744
NCT00257179,The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor,0.0005738730091112194,0.0005320893209823267
NCT00286169,Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC),0.0006435289864932714,0.0008395871843615673
NCT00213733,Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer,0.0006999084904879021,0.0006469453580549321
NCT02366143,A Phase III Study of MPDL3280A (Anti-PD-L1 Antibody) in Combination With Carboplatin + Paclitaxel With or Without Bevacizumab in Patients With Stage IV Non-squamous Non-small Cell Lung Cancer [IMpower 150],0.0007775946046253645,0.0008557776000528943
NCT02397239,Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung Cancer,0.0004376751141529999,0.0007691635888845064
NCT02373917,Characterization of Methylation Patterns in Lung Cancer,0.0016733468092925384,0.000699828796262031
NCT02380196,The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer,0.0007183873659384195,0.0008057737324034426
NCT02335944,Study of Safety and Efficacy of EGF816 in Combination With INC280 in Non-small Cell Lung Cancer Patients With EGFR Mutation.,0.0008839753452695088,0.0009023725434858369
NCT02312622,Phase II Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer,0.0005195514425621797,0.0006724254005802709
NCT02332512,Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR),0.000815003746749264,0.0008137808701425009
NCT02363101,Health Outcomes and Costs (HOC) in Lung Cancer (LC),0.0008761522936284458,0.0006258755615623999
NCT02317016,"Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer",0.0007538592957650589,0.0007630133407809198
NCT02336061,Evaluation of Gender Differences on the Psychosocial and Economic Impact in Patients With Advanced Non-small Cell Lung Cancer,0.0007816351640837718,0.00101752775141025
NCT02350361,Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.,0.00048019108726831886,0.0004914786988973075
NCT02362204,Lung Cancer Nurse Model: a Phase II Study,0.0007515960880182587,0.0005551119517692449
NCT02300298,Nintedanib Plus Docetaxel in Japanese Patients With Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line Chemotherapy,0.0007035017079095531,0.000664548177636279
NCT02308865,Early Palliative Care in Metastatic Lung Cancer in Northern France,0.0005338569787316823,0.00036595964250726507
NCT02308020,"A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain",0.0006175047247956615,0.0007278839115701764
NCT02381808,Study on Potential Biomarkers Associated With Clinical Phenotype of EGFR-TKIs in No-small Cell Lung Cancer in China,0.0006569699593106464,0.0006227703462052131
NCT02388074,Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer,0.00045422885447937207,0.0004877589705203285
NCT02309567,"Is There Any Relation Between Serum Anti-p53 Antibody and TLG, MTV and SUV as PET Parameters in Lung Cancer Patients?",0.0005477406425314192,0.0007354592666889176
NCT02385812,Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma,0.0005095865780666758,0.0004907595249573605
NCT02392728,Virtual Environments in Patients Receiving Treatment for Lung Cancer,0.0009403655567830029,0.0005529831304929806
NCT02320617,Application of Diffusion Weighted MRI Versus CT in Evaluation of the Effect of Treating Lung Cancer,0.0005209992023598283,0.0005688172835116846
NCT02315053,PET Response During Chemoradiation of Lung Cancer,0.0005262461836021706,0.0006304005410312057
NCT02372448,Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients,0.0005441618347749484,0.0008628121895083443
NCT02358473,Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer,0.0007093814213329495,0.0008490797027290443
NCT02318771,"Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer",0.0005901858426253375,0.0006453324597603924
NCT02318368,"A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label",0.0006550268613955727,0.0006872884643993675
NCT02323126,Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer,0.0008094758466995079,0.0009267160515470041
NCT02364804,A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer,0.0006292716546236426,0.0007348253210615534
NCT02364609,Pembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to Erlotinib,0.0007029933853364123,0.0007607575428635438
NCT02394548,Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer,0.0007265649118933817,0.0004936985552875711
NCT02342353,Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI),0.0007076449615288538,0.0007442426296916115
NCT02337712,Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer,0.0005461503730682169,0.0006989679474028073
NCT02331290,Excretion of Acetylamantadine (AA) by Lung Cancer Patients During a Chemotherapy Regimen,0.0007044162135924754,0.0006591763394250708
NCT02348450,Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer,0.0004946127936061927,0.0005879161985179957
NCT02354274,Novel Approach to Radiotherapy in Locally Advanced Lung Cancer - Heterogeneous FDG-guided Dose Escalation With Concomitant Navelbine®,0.0005456987613319984,0.00043059497532823475
NCT02301858,Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases,0.0004652710270995003,0.000437969321036046
NCT02367794,A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-paclitaxel Compared With Carboplatin + Nab-paclitaxel in Participants With Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) [IMpower 131],0.0006635148767097157,0.0007600154744796905
NCT02360761,Surgical Treatment of Elderly Patients With cT1N0M0 Non-small Cell Lung Cancer Comparison Between Sublobar Resection and Lobectomy,0.0007200663297748062,0.0007986242106279262
NCT02393209,Docetaxel With or Without MLN1117 in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer,0.0007137789043702038,0.000828938456668246
NCT02393625,Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer,0.0007580210171995465,0.0007802094403581633
NCT02357992,Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy,0.0007154054879996484,0.0007613439923978698
NCT02357836,Neoadjuvant Itraconazole in Non-small Cell Lung Cancer,0.00071129965241756,0.0009094697871609317
NCT01396551,Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy,0.0006448424336796262,0.0006346459447256888
NCT01351415,A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC),0.000719049759444497,0.0006866302954650872
NCT01351116,A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy,0.0006569504341600384,0.0006783392995469659
NCT01312337,Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC),0.0006475948900939273,0.0005235490804672979
NCT01336634,Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer.,0.0006368216920735705,0.0006836056431871045
NCT01336543,Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC),0.0006036841379574001,0.0007692124641115496
NCT01336192,Maintenance Gemcitabine in the Chinese Advanced Lung Cancer,0.0007368176727287355,0.0007000369178074361
NCT01385111,Combined Application of EBUS and EUS in Lung Cancer,0.0008784155640267961,0.0004689983073122242
NCT01383408,Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection,0.0005175196530152475,0.0005041929552413567
NCT01358942,An Observational Study of Lung Cancer Related Symptoms and Disease Control Rate in Patients With Non-Small Cell Lung Cancer Receiving First-Line Platinum-Based Chemotherapy With or Without Avastin (Bevacizumab),0.0006100572061004818,0.0006586102054896072
NCT01399541,Recovery and Rehabilitation After Lung Cancer Surgery,0.0005299965355363038,0.0004499990383792628
NCT01325753,Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body,0.0005736212510922664,0.0006528191909276546
NCT01360931,The Roles of Neutrophil Elastase in Lung Cancer,0.0008761522936284458,0.0005841055085246086
NCT01389739,Intervention to Improve Continuity of Care in Lung Cancer Patients,0.0006189480686443955,0.0006168820879925088
NCT01356303,Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer,0.0007221973160981208,0.0007488062630967829
NCT01302626,Radiomics: a Study of Outcome in Lung Cancer,0.001070811655088184,0.000519682735579439
NCT01386203,Exhaled Breath Biomarkers in Lung Cancer,0.000639691742692964,0.0006434835223232899
NCT01386385,"Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery",0.0007344016642176882,0.0008546891674061926
NCT01359436,e- Ab Sensor-based Real-time Detection of Mutant EGFR in Clinical Specimens From Patients of Non-small Cell Lung Cancer,0.0006925919362879406,0.0007090658406018589
NCT01310387,Prospective Study of Active Pain Management in Lung Cancer Outpatients (APM),0.0006051925936850453,0.000497830455528455
NCT01310244,Maximum Tolerated Dose Study of Belinostat (PXD-101)in Combination With Paclitaxel Plus Carboplatin in Chemotherapy-Naive Patients With Stage IV Non-Small-Cell Lung Cancer (NSCLC),0.0008127417636473381,0.0007424983290893184
NCT01337037,Modified Video-assisted Thoracoscopic Surgery (VATS) Lobectomy for Early-stage Non-small Cell Lung Cancer (NSCLC),0.000585809255360243,0.0008119316430518657
NCT01391260,Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC),0.0007740353548774859,0.000861434296716226
NCT01344005,Standard Medical Care or Urgent Chest X-ray in Diagnosing Lung Cancer in Smokers With Chest Symptoms Who Are Older Than 60 Years,0.0004178895425776016,0.00038982553823571436
NCT01342965,A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations,0.0007813404969101105,0.0007691139976261689
NCT01342770,Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer,0.0008109323651827591,0.0009446221313132346
NCT01305967,Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer,0.0007625332736809529,0.000920486884864076
NCT01306188,Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients,0.0005515060308872922,0.0005677663079976017
NCT01300299,STEREOtactic Radiation and Chemotherapy in Lung Cancer (STEREO),0.0007160599773214835,0.0006677449492326562
NCT01300429,Molecular Determinants of Acquired Clinical Resistance to Crizotinib in Non-small Cell Lung Cancer Harboring a Translocation or Inversion Event Involving the ALK Gene Locus,0.0005416003122180021,0.00054773845786304
NCT01362842,Psychological and Physical Distress and Care Needs in Operable Lung Cancer Patients Receiving Surgery,0.0005882732785963735,0.0005973596420952886
NCT01362296,An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer,0.000661181141554924,0.0007958074083934276
NCT01309087,Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS CLIA,0.00045885015009891356,0.0005218788185523768
NCT01363557,Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis,0.0006535672924743817,0.0006176174673861472
NCT01313663,A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population,0.0006721976240496506,0.000657780247829946
NCT01394679,A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer,0.0005417446234210206,0.0005166044843952489
NCT00887783,Navelbine And Radiotherapy in Locally Advanced Lung Cancer,0.0006238817336218558,0.0006860139331395539
NCT00880971,To Evaluate Postoperative 3D Conform Radiotherapy in Patients With IIIA (N2) Non-small Cell Lung Cancer,0.0008233673561714819,0.000667916251180223
NCT00871403,Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer,0.0007076136319477036,0.0009311775216922464
NCT00856427,Implantation of Markers for the Radiotherapy of Lung Cancer Patients,0.0006562026856769633,0.0006079269432086587
NCT00898209,Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE),0.0004520388910867427,0.00047693844533636516
NCT00898313,Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer,0.0006225440949340106,0.000576385317161343
NCT00884598,Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung Cancer,0.0006030972796102106,0.0005041498864220855
NCT00807170,Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases,0.0007178809728326873,0.0007192233001182321
NCT00807391,Transbronchial Catheter Aspiration and Transbronchial Needle Aspiration in the Diagnosis of Lung Cancer,0.0004586220673605797,0.0005505053290198046
NCT00831545,"Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)",0.0006183991623842675,0.000688221619649121
NCT00867412,Randomized Study of Positron Emission Tomography - Computed Tomography (PET/CT) in Pre-Operative Staging of Lung Cancer,0.000544888542832285,0.0006626369624385096
NCT00818402,Non-small Cell Lung Cancer and Quality of Life,0.0008935217402910951,0.0007844505775767069
NCT00886678,A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801),0.0008461046182397424,0.0008362035676713148
NCT00830245,A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer,0.0006599299832045517,0.0007946550267587028
NCT00866528,Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer,0.0007117653803953252,0.0007207421355635754
NCT00894127,Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer,0.00045422885447937207,0.0004686111455646878
NCT00852462,Lung Cancer Symptom Assessment and Management Intervention,0.0005129158680985846,0.0005261993182751877
NCT00870532,Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer,0.0008040114757442166,0.0007182172449183224
NCT00870870,A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Patients With Lung Cancer Who Have Not Received Chemotherapy Before,0.0006413006031047768,0.0008453918973693295
NCT00832819,E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC),0.000747592649768646,0.0008487238891639917
NCT00862173,Gene-expression Profiles in CNS-metastatic Non-small Cell Lung Cancer,0.000640057175227616,0.0008209880053850474
NCT00874588,Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer,0.0006734131925929027,0.0006905310067336907
NCT00855894,A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer,0.0007647778374553165,0.0008020181703625772
NCT00897143,Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer,0.0007088124130092092,0.000588762412300736
NCT00897650,Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer,0.0006069359589581459,0.000672001215529977
NCT00826852,Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax,0.0006433792109845619,0.0006932218381443974
NCT00826683,Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC),0.0006018989727398266,0.0005663080771984842
NCT00826033,Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung Cancer,0.0004994729365595727,0.0005338569530067846
NCT00865319,Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC),0.0007586752773367309,0.0006694367229611174
NCT00888511,Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer,0.0007164601329908836,0.0007212987468811069
NCT00836992,"Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer",0.0005990541658609252,0.0005886693691252466
NCT00858403,Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation,0.0006391980026382805,0.0008237204257372361
NCT00858520,"Serum, Plasma, DNA and Tissue Bank in Chronic Obstructive Pulmonary Disease and Lung Cancer",0.0004573045160379496,0.00042577732755882643
NCT00820755,Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC),0.0005847828170341225,0.000708011911304731
NCT00806286,Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer,0.0006614463356251311,0.000685305303455612
NCT00809237,Hydroxychloroquine and Gefitinib to Treat Lung Cancer,0.0006280921131954667,0.0005361191043732534
NCT00883675,Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer,0.0005704504427107121,0.0007669194275620656
NCT00829322,Modafinil for the Treatment of Fatigue in Lung Cancer V9.0,0.0005509115442752165,0.0005435307170193142
NCT00876460,"BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I",0.0007983411464567207,0.000725977650382021
NCT00899457,Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants,0.0005246434399488029,0.0003503326418298649
NCT00899262,"Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers",0.0006313375883826485,0.0005942211350973705
NCT00899028,Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants,0.0007223619709170416,0.0006025730688944347
NCT00899782,Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer,0.0005916824190377207,0.0005839960056460036
NCT00899405,Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer,0.0005863850540389883,0.0004823032661624814
NCT00840749,Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer,0.0006450334187126128,0.0006406398100116863
NCT00851448,"Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients",0.0006139423150849425,0.0003564893432690036
NCT00819728,Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer,0.0007371602541842463,0.0007394628221702222
NCT00864110,Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC),0.0007600705830960796,0.0006314435310621922
NCT01642004,Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017),0.000703352946482779,0.0007804406106819998
NCT01642251,Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-small Cell Lung Cancer,0.0007136190308193813,0.0008204053810380967
NCT01687439,Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC),0.0006156586927315548,0.0006040756597849207
NCT01687738,Lung Cancer Surgery: Decisions Against Life Saving Care - The Intervention,0.0005357635516435919,0.0007662401081423292
NCT01673711,Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung Cancer,0.0005144902839422299,0.0005035949525961888
NCT01620190,Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer,0.0007305138427526262,0.0007125863007819631
NCT01620853,Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test),0.0005757976416397692,0.0006568556498733783
NCT01684696,Virtual Intervention for Lung Cancer,0.0008873150166442339,0.00044983099400986283
NCT01647867,Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers,0.000643134797715558,0.00056884737049961
NCT01647425,Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer,0.0006141742964904006,0.0007848900244631063
NCT01647711,"A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations",0.0006086404490515043,0.0006598220277860154
NCT01656551,"MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer",0.0006658097602561929,0.0008255828516118139
NCT01656460,Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer,0.00044234284889293227,0.0006198543608890849
NCT01610544,18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma,0.0004946891725484517,0.0006503909374226562
NCT01688713,Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer,0.0008977356478557581,0.0006968080171371368
NCT01622621,Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients Non-Small Lung Cancer,0.0006208055737148564,0.000681952625777308
NCT01668823,Photodynamic Therapy in Treating Patients With Lung Cancer,0.0008835059545796534,0.0005865127652561982
NCT01664533,An Observational Study of Erlotinib (Tarceva) as Second-line Treatment in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Failure of Pemetrexed in First-line Therapy,0.0008423444616836651,0.0008501301235951435
NCT01631357,Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer,0.0006419495652452834,0.0006447415975194995
NCT01631526,Vitamin D Loading Dose in Advanced Lung Cancer,0.0007269453771714638,0.0003635513197114767
NCT01685346,Biofeedback Training in Patients With Advanced Lung Cancer - A Pilot Study,0.0006990950714291551,0.0006384460942297515
NCT01685138,LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer,0.0009099481543257808,0.000801206744965003
NCT01660087,Diagnosis of Lung Cancer From Exhaled Breath With Silicon Biophotonic Device,0.000518525786813547,0.00034101714916958314
NCT01661790,Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer,0.000591971639538502,0.0007026009376686972
NCT01682850,Pulmonary Rehabilitation Before Lung Cancer Resection,0.000628330636899904,0.0005462386819197837
NCT01648517,Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy,0.000640156395529687,0.0006794716417049906
NCT01648166,A Population-based Case-control Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens,0.0005334890908101838,0.00043380463091022324
NCT01649947,Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II,0.0009865479933369886,0.0007347870659715864
NCT01670539,Home Telemonitoring for Patients With Lung Cancer,0.0008818744681116138,0.00048495802974384027
NCT01617980,Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer,0.0004546388929506242,0.0007901911484788142
NCT01637376,Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer,0.0006200522560957147,0.0006943197706716777
NCT01658332,Circulating Tumor Cells in Lung Cancer,0.0008805504052592629,0.0006538102297987264
NCT01658813,"5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer",0.00042874078943486,0.0005817376998396313
NCT01624051,A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer,0.0006724842930978642,0.0006393332082380157
NCT01652820,Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer,0.0006475172524925289,0.0006729891014042597
NCT01652469,Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.,0.0005687554041342886,0.000495092047458052
NCT01679743,GRN1005 for Brain Metastases From Breast or Lung Cancer,0.0006325391113778126,0.0006185128798813902
NCT01619241,Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer,0.0006543979968284489,0.0007313416004284457
NCT01619501,Dysregulation of the C/EBPa Pathway in Human Lung Cancer and Search for New Biomarkers and/or Therapeutic Targets,0.0005629325531780912,0.00050038846848403
NCT01037998,UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer,0.0005072310291023883,0.0004583863371885495
NCT01012401,Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer,0.0008872647018061563,0.0005607763045909086
NCT01052818,Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer,0.0006046321644738537,0.0007906456764245562
NCT01082549,Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC),0.0005826614670364221,0.0005377335780670044
NCT01078883,Respiratory Muscle Performance and Functional Capacity in Primary Stage IIIb and IV Lung Cancer,0.0005462122452599717,0.0004982451832387118
NCT01039311,Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer,0.0005177860374999266,0.0004482756820170408
NCT01069575,Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung Cancer,0.0006994269770747234,0.0006772065198446435
NCT01069640,Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer,0.0006994269770747234,0.0006772065198446435
NCT01069328,"Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)",0.0006744382018459417,0.000784262104321634
NCT01058902,The Effect Of Aspirin On Survival in Lung Cancer,0.0008761522936284458,0.00036431120147164403
NCT01058811,Established Lung Cancer Cell Line and Stroma Cell From Surgical Tissue,0.0005929707608598857,0.000526829018347628
NCT01090830,Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer,0.0005970050877301989,0.00062013267179381
NCT01018147,4D Image-guided Adaptive Radiotherapy for Lung Cancer: Patient Image Acquisition,0.0007440025695021658,0.0007053085111827615
NCT01046383,"Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients",0.0007174012901822959,0.0007406218684440821
NCT01086254,SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer,0.0007362560035096293,0.0007052317499681744
NCT01003522,Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer,0.0006780610619158404,0.0005032063301635485
NCT01003964,Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV,0.0005998476733402394,0.000677766583800105
NCT01057212,Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),0.0006457498764544985,0.0005872872091221609
NCT01054482,Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Non-small Cell Lung Cancer,0.0007083985343458024,0.0006289652542443642
NCT01040780,Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients,0.0008935574617670355,0.0011041343535708808
NCT01068210,Lung Cancer Exercise Training Study,0.0006088942681500892,0.00045834854985417486
NCT01014130,Hypofractionated Radiotherapy (Stereotactic) Versus Conventional Radiotherapy for Inoperable Early Stage I Non-small Cell Lung Cancer (NSCLC),0.0006098189098548253,0.0007679537344036413
NCT01014286,Lung Cancer Mutation Consortium Protocol,0.0008761522936284458,0.0005472784978530156
NCT01014598,Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis,0.0007224037578571624,0.0008279543660062951
NCT01006226,"64CuATSM and Hypoxia in Stage IV Non-small Cell Lung Cancer With Carboplatin, Paclitaxel, and Bevacizumab",0.0005850543581171204,0.0006502045426216115
NCT01091376,Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC),0.0007836706735436961,0.0008661491529574572
NCT01064050,Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence in Lung Cancers,0.0004231126477515917,0.0006060901295629477
NCT01041833,Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker,0.0007945822277702989,0.000937479441529002
NCT01051362,Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung Cancer,0.0007496490803545256,0.0007782535372432
NCT01065415,Whole-Body Magnetic Resonance Imaging/Positron Emission Tomography (MRI/PET) in the Staging of Non-Small-Cell Lung Cancer (NSCLC),0.0006042729545669497,0.0007609847021790901
NCT01026844,Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC),0.0006655376834429591,0.0007838407189144659
NCT01027598,"Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer",0.0007298675142886053,0.0007638972774922904
NCT01067794,Chemotherapy in Treating Patients With Lung Cancer,0.0009263415801949624,0.0007526243334879685
NCT01085136,LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib,0.0007151612270035131,0.0007308337597317033
NCT01038271,Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0007635118824380077,0.000783266601356199
NCT01038752,Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer,0.0005775849909190753,0.0007544102252157497
NCT01000428,The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer,0.0006254256243920037,0.000739446473616263
NCT01028729,A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC),0.0006986589772584026,0.0007664276856630636
NCT01048970,Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer,0.0005831949987316223,0.0005733938509864577
NCT01048645,Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer,0.0007559862606420968,0.0008237700393153335
NCT01088620,Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer,0.0007314771730336607,0.0006769190553986334
NCT01022671,Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy,0.0007798161955763728,0.0008176499014474001
NCT01025284,A Study for Patients With Small-Cell Lung Cancer,0.001006483715305589,0.0013384376612602762
NCT01005797,"Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers",0.0004966778535762724,0.0005259987682952955
NCT01011075,Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer,0.0008158582615923649,0.0008120930079273398
NCT01011595,"Minimally Invasive, Diagnosis and Staging of Lung Cancer",0.0006358095745691762,0.0005201739280898932
NCT01060137,Fentanyl Matrix in Lung Cancer Pain,0.0005064486856537727,0.0005530792785494347
NCT01079520,Endobronchial Ultrasound- Transbronchial Needle Aspiration (EBUS-TBNA) Versus Mediastinoscopy for Mediastinal Lymph Node Staging of Non-small Cell Lung Cancer (NSCLC),0.0005599094628864354,0.0006570500592525676
NCT01015443,"Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population",0.0006486830735600456,0.0007160769488933675
NCT01004601,Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer,0.0006456780633663479,0.0007473110887566122
NCT02445183,COPDGene/Lung Cancer Center Database,0.0006215137540187254,0.0004724947127154807
NCT02445872,Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy,0.0006023829114690674,0.0005361948546154509
NCT02459002,"Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot Project",0.0006560707739035331,0.0006245695813281511
NCT02416570,Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?,0.0005506058480525744,0.000774705790948019
NCT02416739,Anticancer Activity of Nicotinamide on Lung Cancer,0.000624491243586768,0.0005667540896779719
NCT02496663,EGFR Inhibitor AZD9291 and Necitumumab in Treating Patients With EGFR-Positive Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor,0.0006974506350531375,0.000780245989827898
NCT02404675,High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation,0.0007927031566021864,0.0009032489578856346
NCT02481830,Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer,0.0006428460212907143,0.0008995635108200968
NCT02481726,68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT,0.0005171717928023381,0.0003802203255940838
NCT02425748,Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation),0.001276530102597968,0.0009367575087161424
NCT02400814,MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung Cancer,0.000813859735434105,0.0006736686497085676
NCT02410369,Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer,0.0006166819757496505,0.0007072564859796958
NCT02410603,Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer,0.0005104034154695921,0.0007035460299720134
NCT02410382,Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer,0.0005879173178015897,0.0006949143321886408
NCT02488928,E- Predict: EBUS ELASTOGRAPHY STRAIN in Lung Cancer,0.000621529112152981,0.000441132509542561
NCT02488694,Maintaining ERBB Blockade in EGFR-mutated Lung Cancer,0.0008761522936284458,0.0006236977716858936
NCT02417662,Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer,0.0007493787524669948,0.0007173538853194416
NCT02437760,The Prognostic and Predictive Value of the CA-125 Marker in Lung Cancer Monitoring,0.00046450803082376523,0.0005130391815676242
NCT02423590,Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers,0.0006908972628834587,0.0007680605165508516
NCT02423148,Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung Cancer,0.0005311252996269683,0.00046666545828444994
NCT02407366,Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer,0.0007488834819408119,0.0006403485513755913
NCT02407912,Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer,0.0007199402773165748,0.000547321828853134
NCT02452463,Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy,0.0007142059856367902,0.0007377785503060266
NCT02470468,Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer,0.0006501475185521094,0.000746898588652118
NCT02412384,The Detection of Circulating Tumor Cells (CTCs) in Patients With Lung Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment,0.0006076467252320419,0.0004677481225690197
NCT02414672,CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer Patients,0.0006813179078590048,0.00043745062021418625
NCT02414139,Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer,0.0008088685188884284,0.0008144135112382148
NCT02462356,Multiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung Cancer,0.0006194899406307847,0.000897810276835939
NCT02499614,Crizotinib in Pretreated Metastatic Non-small-cell Lung Cancer With MET Amplification or ROS1 Translocation (METROS),0.0006603429240934358,0.000526299068055236
NCT02480634,Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer,0.0006482367607905171,0.0006381669023143358
NCT02486718,Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010],0.0006668429743966834,0.0007545495855829987
NCT02484872,Has Inflammation a Significant Implication in Lung Cancer Evolution?,0.0006215432347529521,0.00048366588768237567
NCT02495233,A Study of ASP2215 in Combination With Erlotinib in Subjects With Epidermal Growth Factor Receptor (EGFR) Activating Mutation-Positive (EGFRm+) Advanced Non-Small-Cell Lung Cancer (NSCLC) Who Have Acquired Resistance to an EGFR Tyrosine Kinase Inhibitor (TKI),0.0007006443482536287,0.0006837568054438659
NCT02493114,Functional Status in Patients Undergoing Curative Treatment for Lung Cancer,0.0007486218257097862,0.0006482539111363461
NCT02450539,A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer,0.0007097301970653557,0.000807516408712916
NCT02448303,Pembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung Cancer,0.0006187712574194565,0.0006910848277812451
NCT02448758,Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²),0.001276530102597968,0.00036674822033700506
NCT02448992,Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer,0.0006209554200338126,0.0008283246651241175
NCT02448225,18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules,0.0005669632966301762,0.0004270386231730218
NCT02448797,Icotinib Versus Vinorelbine/Platinum as Adjuvant Therapy in Stage II-IIIA Non-small Cell Lung Cancer With EGFR-mutation,0.0005747113941176867,0.0007461394967369796
NCT02403193,Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0008759766602032676,0.0007023665825354546
NCT02438722,"S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer",0.0006915885011200248,0.0007461599028652367
NCT02490696,Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung Cancer,0.0006922078986165069,0.0007876127213119852
NCT02453282,Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC).,0.0006278808042808348,0.0006492326147293874
NCT02421718,Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation,0.0006035022228625531,0.0005629012661722531
NCT02426658,Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3,0.0007242807088745061,0.0007840665397471675
NCT02408016,Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma,0.0007273632423383934,0.0008063380106681346
NCT02451865,"Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer",0.0007342515283665527,0.0008181331544670201
NCT02497586,Feasibility of Magnetic Resonance Spectroscopy in Lung Cancer,0.0008761522936284458,0.0003820676960338409
NCT02443337,A Study of LY3023414 and Necitumumab in Squamous Lung Cancer,0.0007527091878228308,0.0008190548125496175
NCT02420314,Pharmacological Ascorbate for Lung Cancer,0.0008761522936284458,0.0005992644213561848
NCT02409108,Perfusion-Induced Hyperthermia in Lung Cancer,0.0006226330469915777,0.0005046643453478507
NCT02468024,JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer,0.0005504656946975889,0.0004933522178818404
NCT02468661,"A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification",0.0008419773388650786,0.0007851167370004148
NCT00101920,ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC),0.0006524348543104684,0.0005947747374569644
NCT00187980,Sleep Disturbance in Lung Cancer Patients.,0.0008818744681116138,0.0005691508889397686
NCT00165334,Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer,0.000628825832332715,0.0007619287943000316
NCT00137800,Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients,0.0006491541238739149,0.0007345581815070493
NCT00190710,A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer,0.0007367947352876508,0.0007260185130193296
NCT00184964,Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis,0.0006918466488121384,0.0007050838489670019
NCT00179686,A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer,0.0006259406958717905,0.0006583835538914676
NCT00185913,Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers,0.0005691724434134556,0.0007217707501141728
NCT00119613,A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa,0.0006460029038454297,0.0007134415113963974
NCT00119470,EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer,0.000718548668357428,0.0005268405993916322
NCT00124280,Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0008286191963838916,0.0007946477219060061
NCT00173524,PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC),0.000631996555526834,0.0007701461372280437
NCT00173680,Methylation Status of CD44 Promoter Region in Primary Lung Cancer,0.0008777841998955993,0.0007007826643096513
NCT00125359,Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer,0.0006714073392805487,0.0006824719156253346
NCT00125372,Study of Tarceva and Targretin in Stage I-II Lung Cancer,0.0005669662560747121,0.0006232696119176117
NCT00171834,"Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer",0.0008627259805655795,0.0009625257857927476
NCT00160069,Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer,0.0006408361497520319,0.0008901386359652853
NCT00111839,Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer,0.0005372478645220409,0.0006804606709239753
NCT00193921,Chemoradiotherapy in Patients With Localised Lung Cancer,0.0008844280707461328,0.0006469333022623503
NCT00103116,"Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer",0.0007191464836248028,0.0006546064978059723
NCT00103363,Sputum Cytology in Screening Heavy Smokers For Lung Cancer,0.000514022312702528,0.0005276459330547063
NCT00155116,SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis,0.0004522868639192476,0.00039138252075136376
NCT00136890,PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers,0.0006495508356984914,0.0006363677557217368
NCT00136864,Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial),0.0005903129493778972,0.000539232326110769
NCT00148395,Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.,0.0006589430480344554,0.0007017411821249957
NCT00191191,To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC),0.0007493807982242815,0.0010064992607225988
NCT00191308,Molecular Profiling in Lung Cancer Patients,0.000884480813705725,0.0007862512764575752
NCT00147537,"Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer",0.0005962382775909996,0.0006776670731260607
NCT00144053,A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer,0.0006784460019961857,0.0005818869732707964
NCT00153842,A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer,0.0006856918867818937,0.0006632625904272162
NCT00150657,Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer,0.0006040568058600602,0.000564757733852498
NCT00188890,Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers,0.00051085663366308,0.0003626851519898779
NCT00188214,CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy,0.00045387429863782253,0.0006486029835683022
NCT00172042,A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC),0.0007823103449903489,0.000696331889757527
NCT00115206,Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy,0.0006755658018227072,0.0007154902735538159
NCT00198406,A FRENCH SURVEY OF THE DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF ELDERLY PEOPLE WITH HISTOLOGICALLY/CYTOLOGICALLY CONFIRMED LUNG CANCER.,0.0004477113375682817,0.0003934729044067683
NCT00100256,Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy,0.0006145846958441091,0.0006289075065441398
NCT00152477,A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer,0.0007279114669171792,0.0008398578299612226
NCT00132379,ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer,0.0007998883926988804,0.0008034153814828986
NCT00132522,"EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide",0.0006680567346978904,0.0006079709258184386
NCT00107250,"AZD2171 and Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)",0.0006343486621855809,0.0006975382223498102
NCT00181545,Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients.,0.0007276122757459159,0.0006183867676690116
NCT00108186,Celecoxib Treatment for Lung Cancer,0.000680351601341203,0.0003974246517236088
NCT00175578,Detection of Early Lung Cancer by Serum Protein Expression Profiling,0.0005141413218996379,0.0005156117583051243
NCT00145418,Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer,0.0006679142879357222,0.0006531773803334372
NCT00126581,Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer,0.0007165969288704321,0.0008261124696638831
NCT00129844,Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer,0.0006987607687514268,0.0006986854289051993
NCT00180154,Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET,0.0006154401536267682,0.0009130786741418833
NCT00178256,Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer,0.0004743292513361167,0.0006921211033582399
NCT02178163,Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer,0.0007959908401559327,0.0008227325708457113
NCT02162537,Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases,0.0007536500606965216,0.000775335380694299
NCT02172027,Immunomagnetic Detection of Cancer Cells in Pleural Effusion in Lung Cancer Patients as Additional Staging and Prognostic Tool,0.0005588460460331406,0.0005922554763183878
NCT02195336,dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact.,0.0006270852395083764,0.0006182535682888786
NCT02134015,Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung),0.0007120068231756446,0.0006871892244412961
NCT02157883,"Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)",0.0007310115699210219,0.0006366702072900803
NCT02166658,A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet),0.0006475753696019174,0.0006152974079210412
NCT02166242,Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers,0.000620694703943486,0.000606945690771681
NCT02183870,EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer,0.000881644843507776,0.0006657952936295351
NCT02111681,Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer,0.0004504800687402282,0.0006094232110246526
NCT02147990,"TIGER-2: A Phase 2, Open-label, Multicenter, Safety and Efficacy Study of Oral CO-1686 as 2nd Line EGFR-directed TKI in Patients With Mutant EGFR Non-small Cell Lung Cancer (NSCLC)",0.0007616314554589308,0.0008142351886788823
NCT02193282,Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial),0.0007363391411398864,0.0008244416333215051
NCT02135679,The Detection Of Circulating Tumor Cells (CTC) In Patients With Non-small Cell Lung Cancer (NSCLC) Undergoing Definitive Radiotherapy Or Chemoradiotherapy,0.0007255646825506877,0.0006118033845349764
NCT02152631,A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer,0.0007523459958061984,0.001070876449223608
NCT02192697,An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations,0.0008173772686006007,0.0008987032352211522
NCT02133677,A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases,0.0006322585795764181,0.0005757706089206145
NCT02133508,A Study Examining Long Response in Lung Cancer Patients Treated With Tarceva (Erlotinib),0.0006341659244828067,0.0006010232723844304
NCT02117440,Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer,0.0004997014965059709,0.0005504231449217384
NCT02117908,Study of the Application of CPAP to Reduce Complications and Improve Lung Cancer Ablation Radiofrequency Treatment,0.0005090687141367045,0.0004818252877285395
NCT02179671,"Immune-Modulated Study of Selected Small Molecules (Gefitinib, AZD9291, or Selumetinib + Docetaxel) or a 1st Immune-Mediated Therapy (IMT; Tremelimumab) With a Sequential Switch to a 2nd IMT (MEDI4736) in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer",0.0008321177362270451,0.000692711024956832
NCT02109016,"A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations",0.000665061659255107,0.0006265758155009212
NCT02109549,Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.,0.0007651395959020085,0.0007873688226256474
NCT02191059,Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer,0.0005091732502062535,0.00063129964634658
NCT02191891,BI 836845 Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC),0.0007464699238242014,0.0007865694757202763
NCT02113813,A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations,0.0007315243851804521,0.0006907260954714548
NCT02113852,"Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients",0.000619818220235499,0.0006155632612706828
NCT02121379,Randomized Clinical Trial of 8 Weeks Pulmonary Rehabilitation in Advanced Stage Lung Cancer Patients With COPD During Cytotoxic Chemotherapy,0.0006249138607763466,0.0005288588549398892
NCT02121925,Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up,0.0005587126381097743,0.0004939338517579815
NCT02121899,Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Assessing the Disease-free Survival With Long-term Follow-up (ONC006),0.0004572047722524993,0.0004651228743270571
NCT02121652,Cognitive Behavioral Therapy (CBT)-Insomnia for Lung Cancer,0.0008761522936284458,0.0009707914029657694
NCT02199886,Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection,0.0007704439888743573,0.0006886093964730786
NCT02196844,Yoga Program for Lung Cancer Patients and Caregivers,0.0007077016789465803,0.0005731746050883865
NCT02149576,Does Intense Regimented Surveillance Improve the Rates of Therapeutic Re-Intervention After Lung Cancer Surgery,0.00047620569967249393,0.000615912555702154
NCT02189967,Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation,0.0006471326582097393,0.0007186451715748787
NCT02186847,Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007398226825824218,0.0008456970801383987
NCT02185495,"Screening for Early Lung Cancer in Shanghai, China",0.0008800728214745753,0.0003358966414133086
NCT02151721,Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung Cancer,0.0004900941779506318,0.000480626874047262
NCT02161523,The Impact of Lung Cancer-derived Fibroblasts on Mast Cells Activation,0.000621144691199835,0.00040467386080419705
NCT02161991,Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers,0.0006491224285963204,0.00045984675464029093
NCT02145078,Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer,0.0007112322137363656,0.0007994813635333909
NCT02132884,Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer,0.0007107383754076917,0.0007734355464564989
NCT02132325,Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer,0.0006291543833653047,0.000748216950745648
NCT02182050,Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer,0.0007846811421416451,0.0007179565225839309
NCT02182232,A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer,0.0007161954658537458,0.0008192032846277377
NCT01102517,A Trial on Video-assisted Thoracoscopic Surgery and Axillary Thoracotomy for Resection of Early-stage Non-small Cell Lung Cancer,0.0005615046009483221,0.0006234365925994686
NCT01102231,Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC),0.0006580440149710848,0.000746416888635275
NCT01188707,A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer,0.0007469556451632113,0.0008612887844865643
NCT01188486,Pulmonary Interstitial Lymphography in Early Stage Lung Cancer,0.00047944399572551514,0.0006912888958176385
NCT01140958,A Retrospective Pharmacoeconomic Study of Lung Cancer,0.001070811655088184,0.00045637397823414456
NCT01171924,"A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors",0.0006557780971024658,0.000604230736377472
NCT01161173,An Observational Study of Tarceva (Erlotinib) in Routine Daily Clinical Practice as Second Line Treatment in Patients With Non-small Cell Lung Cancer,0.0007456617099495549,0.0007337397698908998
NCT01179685,Diagnostic Utility of Pleural Fluid MAGE Assay in Patients With Pleural Effusion From Primary Lung Cancer,0.0005766623675706328,0.0005460556862796638
NCT01179308,Regional Anesthesia and Lung Cancer Recurrence,0.000622289257121401,0.00041528384824986934
NCT01159964,"Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery",0.0007036994146419591,0.0008200048426719089
NCT01189435,Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib,0.0005862403581680508,0.0006433118070334182
NCT01153984,A Study of Tarceva (Erlotinib) in Patients With Advanced and/or Metastatic Non-small Cell Lung Cancer With EGFR Positive Mutation (BIOTEC),0.0008105410136156036,0.0007303250474161786
NCT01153399,A Non-interventional Study (NIS) Registry for the Epidemiological and Scientific Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) (Stage IIIB/IV Non-small Cell Lung Cancer).,0.0008612871035863325,0.0007901830253989148
NCT01194453,Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer,0.0006471005577886933,0.0005792517532919847
NCT01158170,Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001),0.0006121496796854652,0.0005921486540684094
NCT01172314,Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients,0.0007145176428877576,0.0005938743741210297
NCT01196234,Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer,0.0006555047251414388,0.0007137736675703791
NCT01141946,Pleural Ultrasonography in Lung Cancer,0.0008789320360881482,0.000639114885958928
NCT01138163,Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer,0.0008117553215074128,0.0007838234632858237
NCT01138358,Study of Episodic Breathlessness in Patients With Lung Cancer or Other Advanced Disease,0.0006709664574459719,0.0006138944169181647
NCT01138748,Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers,0.00045993532433486617,0.0005702676025665742
NCT01138722,Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational Trial,0.0006231025412421617,0.0006355400417269333
NCT01130766,Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC),0.0006520978712640652,0.0006261158820383689
NCT01130285,Validation of a Multi-gene Test for Lung Cancer Risk,0.0006260308265929435,0.0006620363935616118
NCT01130714,Resistance Training in Lung Cancer Patients on Chemotherapy,0.0007375605760812186,0.0006662218026012518
NCT01160601,Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer,0.0006422501236536748,0.0008119933738183205
NCT01133067,Telephonic Contact and Subsequent Physical Follow up Treated Lung Cancer Patients,0.0007082708928068504,0.0006497986842860776
NCT01109524,Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer,0.0006799510400483633,0.0008130501316025821
NCT01192256,Studies Examining the Importance of Smoking After Being Diagnosed With Lung Cancer,0.00045908041373619505,0.0003288830811574411
NCT01192230,Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients,0.0008247027423881054,0.0009065775914110736
NCT01192919,Tumour Registry Lung Cancer (TLK),0.0006408862380160506,0.0006793542508577411
NCT01121393,BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC),0.0005892665790829015,0.0006296450167370218
NCT01134861,Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer,0.0008395585987787397,0.0007419791669923838
NCT01137968,Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC),0.0005956766766910403,0.0007147946834689634
NCT01165216,Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer,0.0006553214978674298,0.0008495780907118109
NCT01124864,A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.,0.0007249413778493824,0.0006735572167610678
NCT01117714,Surgical Versus Non-surgical Staging of Lung Cancer,0.0006520053723706392,0.0006101451139897767
NCT01125995,Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer,0.0005442323707406941,0.0006913794650911619
NCT01178190,The Role of Narrow Band Imaging Videobronchoscopy in Lung Cancer,0.0006241945467313656,0.0005175923053379731
NCT01112631,Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative Radiotherapy,0.0008047097032086687,0.0006274341824305444
NCT01170923,FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer,0.0006213565955437697,0.0004688354386812649
NCT01199068,CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC),0.0006533134960497189,0.0007485259287874793
NCT01199055,CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC),0.0006398117019147303,0.0007064275757430125
NCT01147562,Biomarker Discovery and Validation in Lung Cancer,0.0009002953737997474,0.0006175804871905492
NCT01182155,Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation,0.0006073686926137541,0.0006068941924546723
NCT01185314,To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0008056238005670487,0.0008265823740800253
NCT01185639,Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer,0.0007376987633648675,0.0006604234449836283
NCT01176383,Impact of a Gene Test for Susceptibility to Lung Cancer in Smokers,0.0005156048357782594,0.0003602593384499905
NCT01176487,Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34,0.0006452964556369721,0.0005603263683009754
NCT01193881,RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer,0.0007932245361728747,0.0007685091864402462
NCT01193959,Pemetrexed in Advanced Non-small Cell Lung Cancer,0.0008004134573301866,0.0005933652864359596
NCT01136083,Effect of Exercise Training on Angiogenesis and Cachexia in Lung Cancer Patients,0.0005706940275029922,0.0004889882420070567
NCT01167530,Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer,0.0006974442152686436,0.0006309471005033216
NCT01114958,Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases,0.0006237645918160582,0.0006001135763834732
NCT01101334,Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer,0.0007129743135229202,0.0007901331214445162
NCT02043665,Systemic Treatment Of Resistant Metastatic Disease Employing CVA21 and Pembrolizumab in Non-small Cell Lung Cancer and Bladder Cancer (STORM/ KEYNOTE-200),0.0005670175530997359,0.0006564408772092065
NCT02016209,Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer,0.0005431306319251893,0.0005087597950449322
NCT02016872,"Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients",0.0007067486455154135,0.0007100038072337693
NCT02039674,A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Lung Cancer (MK-3475-021/KEYNOTE-021),0.0005428188661929994,0.0006899242763740883
NCT02000531,Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population,0.0006636888482749138,0.0007369499621370449
NCT02000947,A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer,0.0007166731972579341,0.0009141141406689909
NCT02000518,Emergency Radiotherapy in Metastatic Spinal Cord Compression of Patients With Non-small Cell Lung Cancer,0.000726231982845198,0.0006410499438820829
NCT02070497,Effectiveness of Nursing Case Management for Lung Cancer Patients,0.0006143780856433896,0.0008687993463814337
NCT02034097,A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer,0.0007090588209138364,0.0005859178389060737
NCT02054052,Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer,0.0004563455477882646,0.0003966629496923447
NCT02009436,Inhaled Azacitidine in Patients With Advanced Non-small Cell Lung Cancer,0.000772507918075949,0.0008390419572656775
NCT02009319,Endobronchial Ultrasound Elastography: the Utility of Strain Ratio for Lymph Node Staging in Lung Cancer Patients,0.0005473871222707352,0.0005676231186991057
NCT02093962,Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer,0.000778040538866129,0.000957495402834582
NCT02001168,Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB,0.0006179418190297386,0.0005672150423799778
NCT02066870,Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI,0.0007069371565797184,0.0006481672220287498
NCT02062515,Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency,0.000710906384955049,0.0010472233424782204
NCT02024113,LC-NMR Study Biomarkers to Detect Lung Cancer,0.0007675046867240826,0.0005357855800684656
NCT02094950,Acupuncture Feasibility Trial for Dyspnea in Lung Cancer,0.0006244814543849426,0.00035920922873435967
NCT02087176,A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer,0.0005464877470886411,0.0007665986840398637
NCT02087241,Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer,0.0005448635064473684,0.0008514191293426567
NCT02031601,Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer,0.0007356302584086264,0.000679588514993022
NCT02098954,Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers,0.0006591174006763058,0.0006534940531788822
NCT02049151,Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer,0.0008896343555605386,0.0006100852526731343
NCT02083679,Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer,0.0009074324850036966,0.0005179800048318679
NCT02018523,Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer,0.0006478713546350928,0.0008136805986993038
NCT02079636,A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC),0.0005218240923739207,0.0006602603382437087
NCT02004184,Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction Chemotherapy,0.0006087208715878212,0.0008105345937752172
NCT02075957,"Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer",0.0005539118547718859,0.0005117689714799177
NCT02027428,Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer,0.0006697152929582815,0.0008646735374156528
NCT02027090,High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease,0.000738558746807534,0.0007430465917232445
NCT02029209,To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer,0.0007881949792887161,0.0007839127039034436
NCT02014324,Single Scope Staging of Lung Cancer With Endosonography,0.0006240972172714059,0.0006632315769572039
NCT02073968,PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer,0.0007101406352736014,0.0008696598832100929
NCT02050100,Biomarkers for Diagnosis of Lung Cancer,0.0006509236924530488,0.0005943540333520019
NCT02007070,Study of Pembrolizumab (MK-3475) in Participants With Advanced Non-small Cell Lung Cancer (MK-3475-025/KEYNOTE-025),0.000766291596375936,0.000876782837054942
NCT02007538,Thin Prep Versus Traditional Cytological Procedure for Lung Cancer,0.0008761522936284458,0.0004250850912825913
NCT02095808,Feasibility Study Using Imaging Biomarkers in Lung Cancer,0.0005258703981938235,0.0005083615154463218
NCT02095782,Chemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor Mutation,0.0004971501336273958,0.0004955375090830507
NCT02067858,An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System,0.0005795531087730548,0.0007462617089032385
NCT02084823,Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem Cells,0.000576253194284595,0.0005124862877015341
NCT02030444,Extensive Staging in Lung Cancer,0.0016733468092925384,0.0005115549243420528
NCT02069418,Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient,0.000833151431137341,0.0009031876642316044
NCT02040870,LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib,0.0007666694961450286,0.0007494039581190558
NCT02063828,Reducing Lung Cancer Survivors' Anxiety and Dyspnea (RELAX),0.0006233788083756442,0.0007044500650603983
NCT02059889,Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer,0.0005450163437560854,0.0006513218118749038
NCT02044601,Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT),0.000459870213787636,0.0005508310291398334
NCT02002117,Genotyping of Non-small Cell Lung Cancer,0.0008896590598855437,0.0009191112241718556
NCT00965731,"Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer",0.0007250330718887308,0.0008597237219814935
NCT00983047,Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer,0.0007511268628589789,0.0005937507658141269
NCT00983307,A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer,0.0008438352298936987,0.0008647929408613853
NCT00955305,"Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer",0.0007223642106504775,0.0008173522354695379
NCT00950365,Pharmacodynamic Separation of Pemetrexed and Erlotinib as Second-line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0007850643372424388,0.0007551499214465766
NCT00910546,Image Guided and Breathing Adapted Radiotherapy of Early Stage Lung Cancer,0.0004785075991813793,0.0005317161987837407
NCT00958555,A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer,0.0008005524785508407,0.0009800802248181358
NCT00967083,Support Needs and Preferences of Family Caregivers of Lung Cancer Patients,0.0006153280216571691,0.0005079633832056355
NCT00920010,S9925: Collecting and Storing Samples From Patients With Lung Cancer,0.0012673148055064591,0.0007270442703362823
NCT00973427,DNA Chip Based Prognosis of Lung Cancer,0.0008767104575655317,0.0007510186518072196
NCT00973310,Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer,0.0006977212307548513,0.0009517699240847548
NCT00993499,Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib,0.0007084117257514354,0.0006504047715091732
NCT00923884,Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer,0.000680361280040617,0.0007072626507696493
NCT00923949,Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer,0.0007319614631082791,0.000870588301657521
NCT00995761,Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC),0.0007082094226031591,0.0008301457524287541
NCT00906282,"Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer",0.0006730535821385591,0.0006930959232016602
NCT00979888,Study of How Caregivers Help Patients Cope With Respiratory and Other Symptoms Caused by Lung Cancer,0.0006437102597397294,0.0004932924244842614
NCT00940069,TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer,0.0009873144536308193,0.0006977704734773606
NCT00997724,Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung Cancer,0.0007104865487782146,0.0006845633631779548
NCT00900419,"Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers",0.000546815632695056,0.0005334209478727025
NCT00900328,Study of Tumor Samples From Patients With Lung Cancer,0.0008174070540470345,0.0007081399971354044
NCT00900835,"Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer",0.0005392533553751877,0.0003959247856811787
NCT00905801,Computed Tomography (CT) Perfusion Imaging of Lung Cancer,0.0006237612119367591,0.0006602010115221311
NCT00932152,Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer,0.0005970912386588707,0.0006718267548248418
NCT00976456,Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer,0.0007740433802622811,0.0006934747424976673
NCT00994097,NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer,0.0007591748007609219,0.0008034869961529481
NCT00954278,Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer,0.000763302358568906,0.0007452841305474956
NCT00984243,Photodynamic Therapy (PDT) in Lung Cancer,0.0008783286914617366,0.0005356577128216798
NCT00985998,Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer,0.0007533121999363289,0.0007633161589952829
NCT00988858,A Study of Advanced or Metastatic Non-small Cell Lung Cancer,0.0007846177299126578,0.00082838532297279
NCT00960115,Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy,0.0006496836853405744,0.0008681189126627604
NCT00991796,CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC),0.0006122404421533141,0.0007149730385625306
NCT00913705,Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer,0.0007080207667013154,0.0007883285211286128
NCT00970645,Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung Cancer,0.000611240483041217,0.0004899070733201684
NCT00956852,Study on Systemic and Airway Cytokines and Oxidative Stress in Lung Cancer Patients Undergoing Surgery,0.0006306128664514017,0.0006037036782319945
NCT00071188,ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),0.0006589803204497149,0.0007032807372293235
NCT00071344,Analysis of Brain Metastasis in Patients With Lung Cancer,0.0008910711795000057,0.0007512587701482463
NCT00006017,Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer,0.0007725551047322404,0.0007615020557591735
NCT00006484,Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007216203773394473,0.0007313870965824046
NCT00006470,Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery,0.000715764966436214,0.000830893278679187
NCT00006212,Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer,0.0007253760376223901,0.0008361349992919188
NCT00006229,Paclitaxel and Carboplatin With or Without BMS-275291 in Treating Patients With Advanced or Metastatic Non-small Cell Lung Cancer,0.0007775268266757259,0.0007784283952413669
NCT00006019,"Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer",0.0006612270954081396,0.0007479606906228398
NCT00006877,Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer,0.000803080602189985,0.0009106027628940884
NCT00006929,"Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer",0.0007245465772834984,0.000875899333103872
NCT00006087,Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer,0.0005483336856638932,0.00039958869645572706
NCT00006378,Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007572473935177303,0.0007461042289500204
NCT00006004,Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer,0.0006243171703249845,0.0006481920064022045
NCT00084409,Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease,0.0006178881208655776,0.0005887948453749906
NCT00033527,INS316 Compared With Saline for Sputum Collection in Diagnosing Lung Cancer,0.0004583628107408305,0.0003732192840134413
NCT00016237,"Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment",0.0005757388169477307,0.0006273406600452926
NCT00063219,Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy,0.0007368431513438781,0.0008810461283957708
NCT00063258,Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer,0.0006700231285832731,0.0007751032298308572
NCT00063388,Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer,0.001006483715305589,0.0011666525018762233
NCT00085839,Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2,0.0007778477242891412,0.0007961033737553709
NCT00078260,A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer,0.0007182417270539098,0.0006582720350648178
NCT00012103,Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer,0.0006233987880698412,0.0004012077962424427
NCT00074295,S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer,0.0006577423994733558,0.0005874220536042542
NCT00014066,Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer,0.0007058508652145522,0.0006324786893786865
NCT00049790,Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer,0.0007736037646304692,0.000805622213664757
NCT00049543,"Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery",0.0007155017285807593,0.0008451262427964055
NCT00047840,This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.,0.0008081679649955522,0.0009752226369495195
NCT00047736,A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer,0.0006952162310103431,0.0008533869879295932
NCT00019006,"Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer",0.0006155213120064782,0.0006211930210017039
NCT00019201,Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer,0.00045262829182040893,0.0005322960023195908
NCT00003053,"Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed",0.0007327682762041422,0.0007453715766802583
NCT00003762,Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.000730732495561062,0.0007447231682949207
NCT00003089,"Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer",0.0007675566940794142,0.0008163267912201113
NCT00003869,Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer,0.0007327763834025094,0.0007600743505370919
NCT00003881,Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0007961619232434786,0.0008079925635655757
NCT00003159,Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer,0.0007993124314309,0.0007474630995457352
NCT00003090,Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer,0.0009071162787955213,0.0008790250359478055
NCT00003313,Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer,0.0007257366666412063,0.0007529102629776263
NCT00003284,High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer,0.0006234047340428399,0.0007430772392308692
NCT00003111,Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer,0.0007645354468589506,0.0008811240449616653
NCT00003072,Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer,0.000739519774965361,0.0008400727448583921
NCT00003117,Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0007989631247593477,0.0008019131749963984
NCT00003202,Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer,0.000754066147050979,0.0007393255734505122
NCT00003803,"Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed",0.0007583200129086788,0.0007396166066542155
NCT00003240,Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer,0.0007560759928278048,0.0007754997256388453
NCT00003062,Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer,0.0009084823155219104,0.0008577446413308648
NCT00003974,"Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma",0.0007111226430218525,0.0007735557725616389
NCT00003002,"HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer",0.0006871406244420517,0.0007253099088434714
NCT00003589,Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008516643685415642,0.0007477502554851031
NCT00003901,"Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery",0.0007788388368674317,0.0008080704571477513
NCT00003154,Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008727393794516623,0.0009167997666139799
NCT00003587,S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007568858405589692,0.0008633464428820792
NCT00003831,Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer,0.0007117458764776417,0.0006860011727974785
NCT00003692,Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer,0.0009071111792858328,0.0008425239804921242
NCT00003231,Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer,0.0008060453666749949,0.0008891922075028106
NCT00003562,Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007383687176633342,0.0008977143412705569
NCT00003006,Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer,0.0007481974512624257,0.0006536496899076489
NCT00003900,Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer,0.0007452074386611359,0.000884486104724962
NCT00003317,Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer,0.0007755304927494829,0.000748529605076654
NCT00003447,Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007238156895012938,0.0007567417284857094
NCT00003037,Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007311271986016417,0.0008474619795793557
NCT00003599,Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer,0.00042595725643790257,0.0005366093229721634
NCT00003685,Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer,0.0008137224692376823,0.0007045650678102363
NCT00003387,"Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery",0.0007370413349534468,0.0007506173950808676
NCT00003235,Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed,0.000726081366289049,0.000755382624117251
NCT00003989,"ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma",0.0007388611837259024,0.0008608814868060528
NCT00003666,Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer,0.0007822907048820978,0.0008946425139473956
NCT00003158,S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007572473935177303,0.0008573368520421356
NCT00088933,Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer,0.0005740331595013907,0.0006500725398653446
NCT00008333,Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007537977087053357,0.0008681175789402919
NCT00008385,Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer,0.0007046602835379064,0.000718423599645152
NCT00008255,INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer,0.0007209575534977801,0.0006315888596024636
NCT00055978,Celecoxib in Preventing Lung Cancer in Former Heavy Smokers,0.0006290727680014389,0.0006214403251407085
NCT00040560,Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer,0.000518973192022267,0.0005380591116512646
NCT00040768,Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008451501053818465,0.0008588205331645526
NCT00034957,Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC),0.0008155926064849054,0.0010124608886823898
NCT00034697,Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143),0.0005752540869250917,0.0005930243319206234
NCT00034346,ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC),0.0006704991815555496,0.0006142658300110904
NCT00077883,TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),0.0006428864621476991,0.0007659427227318992
NCT00043823,Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer,0.0006492028854264686,0.0006582089014159513
NCT00099879,Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer,0.0008676819840919423,0.0009655892328886576
NCT00048087,Iressa/Docetaxel in Non-Small-Cell Lung Cancer,0.0007249821405895194,0.0007254396563202472
NCT00059605,Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer,0.0008078932399369493,0.0007778624424302086
NCT00021008,ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer,0.0008858994783266863,0.0008449186509381795
NCT00021333,Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer,0.0005927073369605117,0.0006879924216062971
NCT00020202,FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer,0.0009084830913884646,0.00093706941537197
NCT00020007,Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery,0.0005676256089989363,0.0005416790084122625
NCT00002519,Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer,0.0007329132853347113,0.0008885154781684723
NCT00002667,Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer,0.0008142386698864972,0.0007344409256375557
NCT00002484,Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer,0.0007766726967328616,0.0008038620958080248
NCT00002550,Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer,0.000772939364172905,0.0007722603626882306
NCT00002623,Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007559885515080843,0.0007518515680607135
NCT00002583,Vinorelbine Plus Cisplatin or No Further Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Surgically Removed,0.0007282183433945175,0.0007782778576763792
NCT00002537,Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer,0.0008128500877215365,0.0008974428022631932
NCT00002823,Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer,0.0007704985124405014,0.0008087548475610144
NCT00002911,Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007902340363790384,0.0007008259160883395
NCT00002577,Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer,0.000945471322854522,0.0008374788409541697
NCT00002969,S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007643464174693387,0.0009168615436804836
NCT00002972,Paclitaxel in Treating Patients With Lung Cancer,0.0009073660531175078,0.0007957782438072779
NCT00002624,Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function,0.0007145518354054836,0.0007936471843422485
NCT00002642,"SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer",0.0007559885515080843,0.0008589060603909751
NCT00002852,Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer,0.0007833420881648562,0.0007823631943906036
NCT00002887,Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer,0.0007864672430011247,0.0009208316028104269
NCT00002656,Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008449302569971686,0.000932943128749468
NCT00005868,Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer,0.0007302091602251304,0.000905716775196833
NCT00005065,"Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer",0.000772939364172905,0.0008640054100210254
NCT00005989,R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer,0.0008017149822940748,0.0009099263357245886
NCT00005059,Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer,0.0007274247869704957,0.0008765371561731113
NCT00005055,Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0007713481162499555,0.0007923143519895953
NCT00005037,"Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer",0.0007523135304572105,0.0009051005492693346
NCT00005071,Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer,0.0006606926274610617,0.0006539624063513931
NCT00005872,Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer,0.0009068390414371979,0.0009360975908516602
NCT00005825,Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007568858405589692,0.0009094655255042096
NCT00005091,DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007202293597759212,0.0008908271485822104
NCT00005838,Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery,0.000719504093111413,0.0007336907463170221
NCT00005093,Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008514519686960424,0.0007775697140214137
NCT00005883,Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke,0.0006222622992484817,0.0005013218423447047
NCT00005666,Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer,0.000551000006875222,0.0006784163084590382
NCT00005849,"Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer",0.0007279885919014913,0.0008863503711893214
NCT00005630,Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer,0.0007822098015534906,0.000721852460928523
NCT00086268,Non-small Cell Lung Cancer Study US75 (Z-PACT),0.0010190178728322625,0.0008063660011515236
NCT00050973,"Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer",0.0007399293964512282,0.0008652231660263962
NCT00050960,"Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer",0.0007399293964512282,0.0008652231660263962
NCT00004264,"Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer",0.0007545184447093643,0.0008349247225349101
NCT00004930,Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases,0.0006148440039080673,0.0007722798197691664
NCT00004011,S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer,0.0008060453666749949,0.0007631469059349842
NCT00004138,Positron Emission Tomography for Detecting Non-small Cell Lung Cancer,0.0009041451169400539,0.0007328203487456357
NCT00004209,Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007568858405589692,0.0007795870778148604
NCT00004160,Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed,0.0007425811529544715,0.000859620653412115
NCT00004126,Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer,0.0007849991360022006,0.000903699802011004
NCT00004265,Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer,0.0009260479261230896,0.0009498541516484741
NCT00004096,Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007314519116035662,0.0008907447608171641
NCT00004887,Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery,0.0007400179488376442,0.0007500476205331643
NCT00004253,Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery,0.0007214136891647234,0.0008846748271971028
NCT00004202,"Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer",0.000722369003684719,0.0008424987956336933
NCT00004199,Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer,0.0007391500367626468,0.000711192543702013
NCT00004159,Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor,0.0007367360866989124,0.0008412368472436928
NCT00004093,Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007572473935177303,0.0008519219982363515
NCT00004238,10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007510590775171926,0.0009044619345193269
NCT00004100,Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.000775692481864875,0.0007488353433373985
NCT00004924,Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0007861875486071471,0.0008210324313592293
NCT00004139,Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007162195367163219,0.0007585827306620317
NCT00004151,Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008449302569971686,0.0008987491429431355
NCT00004979,Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors,0.0007426324012100173,0.000854377044635179
NCT00004201,"Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer",0.0007271711277800709,0.0007580340099562676
NCT00004859,"Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer",0.0007250651416321609,0.0007377357163448205
NCT00004883,Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2,0.0007512383881898399,0.0007732550472198887
NCT00080509,Effectiveness of KOS-862 in the Treatment of Lung Cancer,0.0006814907014351431,0.0007933430821375273
NCT00024076,Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer,0.0007835532294384506,0.0008751862497947669
NCT00035152,Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer,0.0006403983729290485,0.0007647885690657482
NCT00056004,Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia,0.0006144356252588377,0.0006490520015278005
NCT00061997,Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers,0.0006188005997551116,0.0005109442187664864
NCT00090961,"S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer",0.000587638551778399,0.0004889267081354602
NCT00097903,Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer,0.0007177687747238411,0.0009978550631431378
NCT00097851,Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC),0.000722843088171767,0.0007565425913466701
NCT00031785,Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer,0.000742478211088848,0.0005664866190829222
NCT01408212,Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients,0.0007065520051999022,0.0008615884961446909
NCT01456429,Assessment of Invasive Mediastinal Staging in cN1 Lung Cancer.,0.0005113142560209051,0.0004384932562474293
NCT01429766,A Prospective Study of Variation in Breath Holding Times at Various Phases of Respiration During the Course of Radiotherapy Including the Effect of Respiratory Training in Lung Cancer Patients,0.0006292166942229217,0.0005051033243622482
NCT01427946,Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer,0.0006294719876621985,0.0007696082425999688
NCT01454102,"Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)",0.0006921866294596448,0.0006482257396790563
NCT01460472,Immunotherapy With Racotumomab in Advanced Lung Cancer,0.0005895852727521881,0.000670665153695873
NCT01465854,French Biological Observatory on Lung Cancer in Never Smokers,0.0006283459886373044,0.00043257103098528723
NCT01419587,Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG),0.0006253987087454967,0.0007911586156715636
NCT01466946,Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients,0.000577234476588665,0.0007610408333243709
NCT01466647,A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC),0.0005346088924704306,0.0006088358047360908
NCT01421953,Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers,0.0006084608658310433,0.0006158240123454717
NCT01407822,Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer,0.0006692393898376558,0.0006687608511156403
NCT01433172,Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer,0.0005378768971001458,0.0006571901087932204
NCT01433263,Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas,0.0006496074718410212,0.0008511648202990232
NCT01482182,"Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy",0.0006919597171441096,0.0007391450286032072
NCT01494883,Mindfulness for Lung Cancer Patients and Partners,0.0008822413712532354,0.0007909106284106302
NCT01441349,Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer,0.0006795554478092423,0.0007768726627736641
NCT01444118,A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer Patients,0.0007570226398137378,0.0008191376135099215
NCT01411098,"Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery",0.0007234147368945796,0.0008147711318669326
NCT01493843,Study Evaluating the Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without GDC-0941 in Patients With Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer,0.0007905738980229232,0.0007681969154340718
NCT01405586,MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer,0.000652921053676332,0.0009256155871545632
NCT01457469,Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer,0.0006194617186558501,0.0006639963131619478
NCT01452971,A Study of the Interaction Between Tumor Susceptibility Gene Glycine N-methyltransferase (GNMT) and Lung Cancer,0.0005437858176492221,0.0004677059773022775
NCT01443078,"Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)",0.0007429354988986253,0.0008183505331443866
NCT01416168,Pilot Study of a Geriatric Intervention After Colorectal and Lung Cancer Surgery,0.0005557592925989351,0.0005424098452445909
NCT01416688,"S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride",0.0005385463147157613,0.0004995418563774256
NCT01481259,Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer,0.0005721345440663763,0.0007492997288411279
NCT01424709,Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC),0.0007387116681798825,0.0006781093529115242
NCT01497041,"A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment",0.0007493407699160071,0.0007653761069948845
NCT01415011,Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients,0.0008071361649902737,0.0008644384162288635
NCT01487603,Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer,0.0008818744681116138,0.0006570914037588253
NCT01473693,Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging,0.0006374856615933395,0.0006266756467483847
NCT01413737,Postoperative Results of Surgical Treatment of Lung Cancer After 30 Days,0.0005737479105543806,0.0008459133063460499
NCT01475500,Nashville Early Diagnosis Lung Cancer Project,0.0006275432309825153,0.00042707305230522816
NCT01498562,Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung Cancer,0.0007026324105444709,0.0005971671075625798
NCT01498055,Autologous CIK Cells Infusion for the Treatment of Lung Cancer: a Randomized Controlled Study,0.0005029077395684653,0.0007268887617813023
NCT01296113,Chemotherapy for Lung Cancer in HIV-positive Patients,0.0007446572976269252,0.0007916267744314711
NCT01284348,Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer,0.0008373835969880294,0.0009021112297776425
NCT01221077,Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene,0.0008304793040273312,0.0007868033483918872
NCT01287754,A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations,0.0008102645539623682,0.0007272648594276203
NCT01287962,Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer,0.0007190907746819074,0.0007547324072370891
NCT01270399,Targeting ER-Golgi Homeostasis in an Advantageous Therapeutic Strategy in Lung Cancer,0.0004858932890776158,0.00037838697096731716
NCT01270386,A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer,0.0008468105806581319,0.0007641548747952178
NCT01213745,The Use of a Quality of Life Questionnaire in Patients With Lung Cancer,0.0007080910520862481,0.0007536311196957619
NCT01266512,Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer,0.0004630582537672052,0.00037499171440111344
NCT01261585,Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT,0.0007056440967963763,0.00048008788837704844
NCT01259284,Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer,0.0005476835761357558,0.0005266809724717392
NCT01282450,Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC),0.0007378867784052517,0.0008540293769216241
NCT01282151,TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer,0.0006327099388689019,0.000698602650213322
NCT01210378,Nitroglycerin in Non-small Cell Lung Cancer,0.0008885385111076768,0.00068951321591216
NCT01219348,IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients.,0.0006246353910786483,0.000510957917940448
NCT01203735,Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung Cancer,0.0007102576953041834,0.0005308469643497249
NCT01246297,Effect of Pulmonary Rehabilitation in Lung Cancer Survivors,0.0008794540655238326,0.0005054599459443959
NCT01280448,"The Correlation Between Lung Cancer Susceptibility, Drug Response and Genetic Polymorphism",0.00045795021533089265,0.000492344057992839
NCT01281787,PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer,0.0008772732130977363,0.00042897775035210183
NCT01291017,"Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.",0.0006220082592966234,0.0007834282701791589
NCT01262560,Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer,0.0005851415628355073,0.0004883977899571646
NCT01262820,Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab,0.0004656180139485831,0.0005361101239226571
NCT01211483,Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer,0.0007129743135229202,0.0007838921928917642
NCT01211002,Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC),0.0006907485887434196,0.0008756426964081324
NCT01240447,Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients,0.0007532419147846131,0.0007964357103820227
NCT01240369,Association Between VEGF-C and miRNA and Clinical Non-small Cell Lung Cancer and Esophagus Squamous Cell Carcinoma,0.0006214892565656059,0.0006290899881615071
NCT01263886,Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer,0.0007001489185184291,0.0007559308882890194
NCT01297491,Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer,0.0009337452798445828,0.0008447791814121781
NCT01218594,Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer,0.0006074545960890922,0.0007296107419290956
NCT01274468,Tumor Markers in Lung Cancer,0.0006549160289126075,0.0008526539745478474
NCT01244191,"ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer",0.0005736943839954017,0.0006196297443653402
NCT01257139,"Trial Involving Subjects Over 70 Years of Age With Non Small-cell Lung Cancer of Stage IV and Comparing a ""Classical"" Strategy of Treatment Allocation, With an""Optimized"" Strategy Allocating the Same Treatments",0.00046328575810006224,0.000610609147151252
NCT01257308,Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients,0.0005833881969843558,0.0008226576073671102
NCT01255059,GWAS Research of Lung Cancer in Tianjin,0.0016733468092925384,0.0011100670417907436
NCT01207011,Amrubicin (AMR) Trial in Patients With Non-small Cell Lung Cancer,0.0009071146062093156,0.0010072779574337655
NCT01207063,Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC),0.0007854182495812402,0.0006539407805535995
NCT01201044,Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC),0.0006911216148570247,0.0009999205115818158
NCT01230710,A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression,0.0008291186389825199,0.0007923988456698176
NCT01278888,"Minimally Invasive or Open Surgery for Lung Cancer: Pain, Quality of Life and Economy.",0.0004531021704747099,0.0005119460359397467
NCT01258478,Lung Cancer Rehabilitation Study,0.0007523457935269085,0.0005530870141604623
NCT01258127,Pemetrexed/Carboplatin vs Vinorelbine/Carboplatin in Patients With Completely Resected Non-small Cell Lung Cancer (NSCLC),0.000709944255240903,0.0006760299665521023
NCT01290809,Prophylactic Cranial Irradiation (PCI) Cognitive Tests in Non-small Cell Lung Cancer (NSCLC) Patients,0.0007439600543671833,0.0006750565728649423
NCT02941003,Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer,0.0004888620064579689,0.0004944635982225129
NCT02921191,"Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated",0.0006144545895615685,0.0005551802622541956
NCT02917369,Integrative Analysis of Large-cell Lung Cancer,0.0016733468092925384,0.002397410574011457
NCT02907606,Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study,0.0007146324162956635,0.0008215798591865599
NCT02973789,Effect of Tumor Treating Fields (TTFields) (150 kHz) as Second Line Treatment of Non-small Cell Lung Cancer (NSCLC) in Combination With PD-1 Inhibitors or Docetaxel (LUNAR),0.000587869924696519,0.0006958651906263986
NCT02997449,Complete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom SABR is Considered,0.0007042247642735335,0.0008579523587537138
NCT02954809,"Effects of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors",0.000422951876028863,0.0005353155514337772
NCT02980809,Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer,0.0004911538919186847,0.0007781490335236496
NCT02938546,18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study,0.0006283583650526257,0.0006432254348502328
NCT02904954,Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage IB and II Non-small Cell Lung Cancer,0.0006539186128907702,0.0008014334778858433
NCT02968979,Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer.,0.0007564475728452611,0.0008538919083828755
NCT02956551,Neoantigen-primed Dendritic Cells (DC)- Pre-activated T (PreT) Cell Therapy for Refractory Non-small Cell Lung Cancer,0.0007121197328097764,0.0009849672729941848
NCT02992353,"Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer",0.0007128008107910304,0.0006358031678521191
NCT02994576,Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer,0.0007121190506530608,0.0006599957088817755
NCT02936323,PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers,0.0006846856502684585,0.0006597857076698226
NCT02936804,Precision Diagnosis and Therapy for Early Stage Lung Cancer,0.0005992115203743846,0.0005264596661094062
NCT02978521,Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients,0.0008469246872006879,0.0007631016630374641
NCT02931461,Interest of Procore Needle® for Diagnosis of Lung Cancer,0.0005172008828592007,0.00047370021707678506
NCT02984761,Veterans Affairs Lung Cancer Or Stereotactic Radiotherapy,0.0008783738536053495,0.0007955149799223534
NCT02963610,Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer,0.0007644858408424606,0.000767168846874482
NCT02989974,Kentucky LEADS Collaborative: Lung Cancer Survivorship Care Program,0.0008811294717595688,0.00045130013134385785
NCT02961270,Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation,0.0011496633366279297,0.001206087048844037
NCT02965391,Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer Patients,0.0006463048459726666,0.0006419545601094712
NCT02962115,Development and Pilot Testing of a Clinical Informatics Lung Cancer Screening Intervention,0.0005136736641695413,0.0005716630257771271
NCT02974933,Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer,0.0006681905681901976,0.0008216414743945704
NCT02991924,Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer,0.0005086615576066572,0.0004483320403130234
NCT02933294,Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer,0.000547631920678451,0.00046956559638878874
NCT02927340,A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions,0.0005508142599634347,0.0007486780887302609
NCT02976116,A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer,0.0008048939544507169,0.0007548461351672181
NCT02922777,Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.,0.001276530102597968,0.0009064401655675174
NCT02995889,FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer,0.0005814814957789512,0.0007128799862244224
NCT02959619,Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK,0.0007857982712450312,0.0009640547163923899
NCT02942043,Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer,0.0006609778699810803,0.0008880688194840614
NCT02971501,Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases,0.0006949897274973608,0.0007386949888261182
NCT02955758,Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer,0.000805369995844455,0.0009420186253715794
NCT02955290,CIMAvax Vaccine and Nivolumab in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer,0.0007459848522958429,0.0008107810673466479
NCT02972177,Transbronchial Ablation for Peripheral Lung Cancer,0.0008767227589738093,0.0008839385801669848
NCT02966769,N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation,0.00047471415032110083,0.000630256799493004
NCT02947386,Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer,0.000775603304821724,0.0007525963153199385
NCT02967133,A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer,0.000702687833520828,0.0006838706590911301
NCT02937818,"A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer",0.0008052351654949961,0.0008256908067641604
NCT02916147,Effect of Different Anesthetics on the Change of Alarmins in Lung Cancer Patients Receiving Pulmonary Lobectomy,0.0005714276226287972,0.000537872322682578
NCT02916745,Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer,0.0004257064559883573,0.0006041127547692055
NCT02538380,EUS-B-FNA vs EUS-FNA for Left Adrenal Gland Analysis in Lung Cancer Patients,0.0007044974004497533,0.001138035958880972
NCT02500810,Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients,0.0005925680395498906,0.0006620502706381978
NCT02589522,VX-970 and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer,0.0007504123512493198,0.0008024059309871453
NCT02507518,Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung Cancer,0.0005144817531615553,0.0007959921950452041
NCT02542930,Abscopal Effect for Metastatic Non-small Cell Lung Cancer.,0.0007351573530921593,0.0008096171805389104
NCT02542293,Study of 1st Line Therapy Study of Durvalumab With Tremelimumab Versus SoC in Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE).,0.0006524065048855517,0.0006562965992754425
NCT02566993,"Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin (DOX) Versus Cyclophosphamide (CTX), Doxorubicin (DOX) and Vincristine (VCR) (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer",0.0006917406079597364,0.000573246783165305
NCT02578680,Study of Platinum+Pemetrexed Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Non-squamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189),0.0006596740294562514,0.0006880502825953284
NCT02504801,Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD,0.0007038542844005694,0.0005096296913941723
NCT02504372,Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091),0.0006117581948001524,0.0006596232957785501
NCT02504697,DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer,0.0006490672509299927,0.0005250399822166599
NCT02504346,"AZD9291, an Irreversible EGFR-TKI, in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI, Coupled to Extensive Translational Studies",0.0007827327419762357,0.0007717154343306706
NCT02570815,Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer,0.00044862101872898235,0.00040229284329886217
NCT02519972,Low-dose Computed Tomography Screening for Lung Cancer in Relatives With Family History of Lung Cancer,0.0004235377011868633,0.0003566977372562129
NCT02573506,Study of Consolidation Chemotherapy For Bulky Local Advanced None-small Cell Lung Cancer,0.0006981106987158322,0.0007881729001734455
NCT02556593,IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases,0.0006379095893048175,0.0007924154144223379
NCT02502318,Medicoeconomic Evaluation of Two Surgical Techniques for Lobectomy in the Lung Cancer,0.0005461261812627159,0.000581955117866696
NCT02502695,A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS),0.0008057195779918226,0.0006179100638580387
NCT02505685,Dynamic PET CT as a Tool for Treatment Efficacy Monitoring in Lung Cancer,0.0005634121084336362,0.0007602276507683083
NCT02588261,A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations,0.000806511524811891,0.0008381010040517957
NCT02520778,Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer,0.0007410852572574998,0.0008134681204580066
NCT02540174,Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer : Interest of an Addiction Treatment,0.0005660705917821378,0.0005789315378731337
NCT02540824,Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer,0.0006995766937831767,0.0007282080513806684
NCT02551211,Association Between Circulating Immune Cells and the Tumor Immune Contexture in Resectable Non-small Cell Lung Cancer,0.0005835246697730219,0.0007191136297839569
NCT02513355,Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research,0.000634714925071847,0.0005595274240372359
NCT02579005,Radio-Immuno-Modulation in Lung Cancer,0.0006207784358235478,0.0005182753209005887
NCT02577393,Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy,0.000640296587839026,0.0005957600595425103
NCT02596490,Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners,0.0006350321461558774,0.00040074570526190035
NCT02596958,Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants,0.0006199392627811378,0.0006551784895540351
NCT02572843,Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC),0.0007851836069833433,0.0005898665525978314
NCT02511288,LIquid BIopsies in Lung Cancer (LIBIL),0.0016733468092925384,0.000602674671423952
NCT02535325,"Methoxyamine, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer",0.0007271931098055487,0.0008325537090002694
NCT02535338,Erlotinib Hydrochloride and Hsp90 Inhibitor AT13387 in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer,0.0007358204012779421,0.0007195859132576246
NCT02549261,Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer,0.0007258636871434373,0.0007416354190022985
NCT02522910,An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0008485294835532507,0.0007747780951190154
NCT02546986,Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer,0.0007846177299126578,0.0007038886986908678
NCT02532062,The Pittsburgh Vitamin D Study: Vitamin D Supplementation in Vitamin D-deficient Subjects at Risk of Lung Cancer,0.0006055626503182651,0.00044212137529558293
NCT02531464,Intervention to Improve Supportive Care for Family Caregivers of Patients With Lung Cancer,0.0005746606693296587,0.0005735450392744
NCT02531737,Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With Lung Cancer,0.0005892830390191489,0.0008418755241949839
NCT02515435,The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer,0.0007904126944710821,0.0007204343187283349
NCT02515760,Tumor-specific T Cells in Lung Cancer,0.0005236078419238136,0.0005640738656090918
NCT02568033,Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer,0.0006200522917562671,0.0007567048325397539
NCT02528942,Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients,0.0005829858053832993,0.0006258247756354498
NCT02599454,Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer,0.0007828247007729127,0.0008178786856264612
NCT02595944,Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer,0.0007495389730473146,0.0008401862269229498
NCT02595450,A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer,0.0006092050525137085,0.0007408549805225062
NCT02595840,"A Prospective, Multiparametric Biomarker Study to Identify Predictors of Treatment Response and Resistance in Patients With EGFR-mutated Non-small-cell Lung Cancer Receiving Maintenance Therapy With Either Afatinib or Pemetrexed With the AIO-TRK-0114 Study (MARBLE)",0.0006497111635600874,0.0006067482025499197
NCT02580708,A Phase 1/2 Study of the Safety and Efficacy of Rociletinib When Administered in Combination With Trametinib in Patients With Activating EGFR Mutation-positive Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),0.0008305773257778187,0.0008009592354038404
NCT02590965,A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer,0.0007729718746418562,0.0006593107018643079
NCT02590003,Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer,0.000579552108140804,0.0007489047002966256
NCT02581943,Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer,0.0007172461792769531,0.0008352310095383594
NCT02581787,SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer,0.0005975270336923354,0.0006796115790128384
NCT02562027,SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer,0.0006160601546281568,0.0005955986645989828
NCT02575560,Weekly Use First-generation EGFR-TKI in the Treatment of EGFR-TKI Acquired Resistance Non-small Cell Lung Cancer (NSCLC),0.0006018528559402892,0.0006904205315106236
NCT02597738,A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine,0.0005078706968501501,0.0005004707540861768
NCT02525653,Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers,0.0007005389214390774,0.00079269379280821
NCT02525757,MPDL3280A With Chemoradiation for Lung Cancer,0.000882833698549245,0.0006139317383770445
NCT02501668,The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease,0.0008818744681116138,0.0004019387511092488
NCT02503722,TORC1/2 Inhibitor INK128 and EGFR Inhibitor AZD9291 in Treating Patients With Advanced EGFR Mutation Positive Non-small Cell Lung Cancer After Progression on a Previous EGFR Tyrosine Kinase Inhibitor,0.0007262101503907168,0.0007936257385354772
NCT02503358,Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer,0.0007366821492301624,0.0007747425693486353
NCT02523404,HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Lung Cancer,0.0005559802076898215,0.0008838676764210668
NCT00685750,Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma,0.0005817059035217557,0.0007004041024227466
NCT00687297,Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer,0.0007225540567589421,0.0006622477525168717
NCT00687986,Trial of Either Surgery or Stereotactic Radiotherapy for Early Stage (IA) Lung Cancer,0.0005004622074016396,0.000617924515578581
NCT00621361,"Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients",0.0006162299437746291,0.0006402359323382466
NCT00676507,Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy,0.0006461340659706066,0.0006806844565610444
NCT00614484,Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer,0.0006099783307463422,0.0008636372910990888
NCT00633568,Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer,0.0008087410288848568,0.000683127744849827
NCT00633724,Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer,0.0009095899611779857,0.0007443003257757592
NCT00662311,"Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery",0.0006012092576898473,0.0008191176156821346
NCT00652340,APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer,0.0007738598428716399,0.0007366850391878603
NCT00636571,Feasibility of Exercise With Post-Op Lung Cancer Patients,0.000884464596231741,0.0005502817501203607
NCT00673049,"Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer",0.0009150749550676261,0.000663343608957258
NCT00673283,Early Detection of Lung Cancer Via Bi-plane Correlation Chest Imaging,0.0005157274144499198,0.00030279838284941375
NCT00600821,A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.,0.0006897066855179791,0.0007079849986097742
NCT00600015,Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC),0.0006374812087687952,0.0006498538854017492
NCT00611598,DNA Repair and Genetic Susceptibility to Lung Cancer,0.0005102055447756554,0.00047072519585634814
NCT00683904,Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer,0.0007472326361951237,0.0008863010268689263
NCT00657423,Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC),0.000645345755956665,0.0006865452888814637
NCT00681512,The Effect of Berries on Lung Cancer Tumors,0.0009027174333772388,0.0010169965856113873
NCT00682383,Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC),0.0006230128182458932,0.0005295566566607512
NCT00684385,An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck,0.0006859326021249383,0.0006825082545617173
NCT00603057,Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer,0.0004409390022799579,0.0006753924884757162
NCT00603538,"Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer",0.0005962382775909996,0.0007395874721127157
NCT00635596,"Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer",0.0005959802427832406,0.0005323397519940022
NCT00658580,Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer,0.0006267141987490884,0.0006711064213171881
NCT00656136,BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1),0.0006900922015002235,0.0006330433049596752
NCT00691132,Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers,0.0006283467515175851,0.000428986300281439
NCT00639067,Breath Test for Early Detection of Lung Cancer,0.000625306894011743,0.0005941175512496984
NCT00675168,Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General Practice,0.0005632529701870048,0.0005870295560391017
NCT00675597,"Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer",0.0007038119372738659,0.0006982297359466354
NCT00690924,Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer,0.0005150273647157736,0.0004065360138203107
NCT00601796,"Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer",0.0005887675839974332,0.0006620373396145865
NCT00661778,A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer,0.0008292370982410745,0.0007989764676943411
NCT00693836,"Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region",0.0007069280601433675,0.0004714033346549209
NCT00622193,Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer,0.001006483715305589,0.0013873053938652216
NCT00622349,Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer,0.0007265643108243415,0.0007176848721570444
NCT00698815,Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007097698910386567,0.0007942639695030728
NCT00666692,"A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)",0.0007090343547376714,0.0007659274930233858
NCT00686322,Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC),0.0005071864106586165,0.0005996629207227662
NCT00380666,The Utility of PET/CT in the Planning of Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer,0.0006263851929171086,0.0004751905148516153
NCT00398970,Utility of Endobronchial Ultrasound in the Investigation of Suspected Lung Cancer.,0.0006412800339355512,0.0005389249235115857
NCT00349492,A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer,0.0005055149741299566,0.0005705187072516371
NCT00349102,Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer,0.000646794172511574,0.0005684938898495253
NCT00349089,Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy,0.0006728169607519128,0.0005191128938541649
NCT00338481,"""Red Morphine Drops"" for Symptomatic Treatment of Dyspnoea in Lung Cancer",0.0004553609211016555,0.0004967144211909664
NCT00373204,Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere),0.000626462078382382,0.0006840948028291597
NCT00347412,Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer,0.0006652305556102314,0.000724507373235594
NCT00303901,Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery,0.000590021446571612,0.0006851870709271865
NCT00301119,Lung Cancer Biomarkers and Screening,0.0006398199808249735,0.0005825475435981825
NCT00340405,"Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China",0.0005056716264771559,0.0005129063991901334
NCT00340340,Genetic Epidemiology of Lung Cancer and Smoking,0.0005102998182273158,0.00048218110045215965
NCT00340847,Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer,0.0004487125759961423,0.0005576232275938793
NCT00368927,Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia,0.00045489171154951323,0.000374581663781076
NCT00315185,"Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer",0.0005797711995419622,0.0005764550383953114
NCT00326378,Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer,0.0007255322212888278,0.0008206494789612107
NCT00370383,A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC),0.0005407991927133779,0.0008637191783509499
NCT00363428,Lung Rehabilitation in Treating Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Surgery for Lung Cancer,0.0006333210871230131,0.00043461829648951074
NCT00363805,Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease,0.00045421719985310545,0.00037055985778573503
NCT00345059,The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer,0.0007078069221605265,0.0007234303125657165
NCT00345891,Quit Smoking Program for Lung Cancer Patients' Families (The Family Ties Project),0.0005731486927169222,0.0006214618039241087
NCT00397124,The Role of the Vagus Nerve in Tumor-to-Brain Communication in Lung Cancer Patients,0.0005819488214303943,0.0005913294663025793
NCT00372788,"AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen",0.0007242977813070551,0.0008138748960966318
NCT00342836,Analysis of Tissues From Patients in Trial of Myo-Inositol to Prevent Lung Cancer,0.0006185336059095754,0.0005692587564522537
NCT00342264,A Nested Case-Control Study of Lung Cancer and Diesel Exhaust Among Non-Metal Miners,0.0005320092385836246,0.0004302776394870055
NCT00316225,Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen,0.0006151513160108545,0.0007358835603680962
NCT00365105,"Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer",0.0005319215600733738,0.00038418501733718583
NCT00365963,Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers,0.0008894967249850935,0.0004943223125648097
NCT00329472,Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer,0.0007176912820110085,0.0007640277649920557
NCT00313690,Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer,0.0006654425655099666,0.0006722266251366582
NCT00364624,Adrenal Function in Patients With Newly Diagnosed Lung Cancer,0.0006244497301606383,0.0004937098203988745
NCT00364780,Study of XL647 in Subjects With Non-Small-Cell Lung Cancer,0.0010190178728322625,0.000642278219800366
NCT00325494,"A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer",0.0004948491445480408,0.0004677903250561376
NCT00330746,CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer,0.0006738001312760565,0.0008185535931798469
NCT00321893,Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer,0.0006205729685971247,0.0004967074284686997
NCT00391248,Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL),0.000664512576538175,0.0006669578093129164
NCT00312819,Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer,0.00045085639370238446,0.0006547502566637839
NCT00312377,ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer,0.000636549783276294,0.000803194070804641
NCT00341380,Prevention of Tumor Spread Due to Lung Cancer Surgery,0.0005442841469333387,0.000668020823049649
NCT00341835,Genetic Epidemiology of Lung Cancer,0.0006249501580705229,0.0005365504632151962
NCT00322751,Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer,0.0006849913233925281,0.0005809691863571197
NCT00300586,IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer,0.0008473758828786734,0.0006567587551608964
NCT00390806,Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer,0.0004889726110678787,0.000615117484050422
NCT00339859,"DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer",0.0008767234034780759,0.0007990905771909593
NCT00324805,"Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery",0.0007344063007954909,0.0008227079940386371
NCT00791336,Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer,0.0006539153482953111,0.0009417213835917875
NCT00723957,A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer,0.0006773847124615852,0.0007403146038250452
NCT00794547,Phase I/II Calcitriol in Lung Cancer,0.0008767226522581862,0.0008531280863819982
NCT00741247,Mediastinal Staging of Lung Cancer With EBUS-TBNA and EUS-B-FNA,0.0006222711725231912,0.00044503974540377955
NCT00741988,Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer,0.0006460749689033897,0.0006898296399014884
NCT00783705,Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia,0.00045533506710185566,0.00038346252232065287
NCT00749346,NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer,0.0006225987924370104,0.0007407460348013029
NCT00749567,Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer,0.0007489823755278587,0.0008149158013079698
NCT00738881,Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0007380236796387787,0.0007884331646147866
NCT00738387,A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer,0.0006806369191023288,0.0008378322310732947
NCT00733252,Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease,0.0005064315206413493,0.0004177474297084657
NCT00724581,Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer,0.0005861791756428656,0.00046236239759282207
NCT00735878,Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer,0.0007138296208624998,0.0006976995689088601
NCT00735696,A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer,0.000729757422567754,0.0007969206154580096
NCT00798720,Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer,0.0006582152793466024,0.0007884571337707918
NCT00707304,Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer,0.0011496633366279297,0.0009917060750458426
NCT00706862,Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer,0.000811093341126495,0.0008124130358371479
NCT00751660,Screening Methods in Finding Lung Cancer Early in Current or Former Smokers,0.0004560059200550424,0.0003812854965829787
NCT00745160,Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes,0.0005677418201593441,0.0006035395378593148
NCT00702975,Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy,0.000835741260292824,0.0007895890974191132
NCT00752076,Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment,0.0007242294927369558,0.0009467849080586015
NCT00752115,Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer,0.0007482611996778179,0.0007355487933971887
NCT00717353,Genetic Polymorphisms in UGT1A6 and UGT2B7 in Asian Population: Association With Lung Cancer Phenotype,0.0005093473010458319,0.00048397623681549425
NCT00717795,Physical Activity Intervention for Lung Cancer Survivors,0.0005186843708980994,0.0005335629696151326
NCT00717002,Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study,0.0007230558119937691,0.0007597421656769849
NCT00799240,MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer,0.00045001184148104397,0.0006364513551208623
NCT00701870,Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non‑Small Cell Lung Cancer,0.0007860866762004347,0.0008218025977277248
NCT00737867,Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer,0.0006468560828320215,0.0007875037345195128
NCT00732810,SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716),0.0007624927913310016,0.0006990676868021095
NCT00721981,An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy,0.0007631352468026917,0.0007788335920642828
NCT00708812,Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer,0.0007610214742846433,0.000595023884261091
NCT00705549,"Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer",0.0007177331844598602,0.0007452058160651382
NCT00425191,Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.,0.0006219540377842876,0.0007013253262667394
NCT00425022,VATS Lobectomy for Clinical Stage IB or II Lung Cancer,0.0004896256898489337,0.0005667031773994824
NCT00466466,Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients,0.0006481785955761834,0.0007009792417254009
NCT00465907,"Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer",0.0005646101684446597,0.0006927409126218038
NCT00442754,Dendritic Cells in Lung Cancer,0.0008833459971743064,0.0004910392770779118
NCT00491699,Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer,0.0010190178728322625,0.0006476388262950996
NCT00441922,Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC),0.0007353899335325548,0.0008747434934856563
NCT00464282,Fluorine-18-α–Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer,0.0006502541905176009,0.0005817181700966485
NCT00457119,"Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients",0.0006164628814962148,0.0006889812374916228
NCT00492843,Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis,0.0005720644901359443,0.0005209595711856148
NCT00481624,Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia,0.0006206840217042834,0.0005532752975766578
NCT00437749,A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer,0.000828780445644617,0.0007297867775812496
NCT00487760,African American Families and Lung Cancer Study,0.001070811655088184,0.0005600736077112125
NCT00487669,Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC),0.0006907675402336484,0.0006804367415597782
NCT00431015,"Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)",0.0006729632510807767,0.0008510326328684267
NCT00409188,Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START),0.0006248750846342481,0.0006491265242430943
NCT00400803,Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer,0.000621144983865161,0.0007936876604110474
NCT00444015,Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC),0.0006625752674794242,0.0006117884967676096
NCT00440960,Anesthesia in Flexible Bronchoscopy for Lung Cancer Diagnostic,0.0005177817655181822,0.0005608358640968671
NCT00415363,"Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy",0.0006609600319054994,0.0007352638608482679
NCT00422500,Longitudinal Study of Multiple Symptoms in Advanced Lung Cancer,0.0006869107044297191,0.0006790550736830768
NCT00473083,Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer,0.0004690034720159691,0.0004171482153715948
NCT00452413,A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer,0.0005593127223280395,0.000770193048707579
NCT00452075,Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for Chemotherapy,0.0008066219503554981,0.0008519250835957758
NCT00402883,"Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer",0.0007324636498377836,0.0007609447424646542
NCT00424853,ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC),0.000509369598142358,0.0005543134144295037
NCT00462995,Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT),0.000494189658275528,0.000787669681491352
NCT00490659,Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes,0.0005775410388688942,0.0006694694520312965
NCT00411593,Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC),0.0009453794044022727,0.0007429662886737092
NCT00406302,Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC),0.00048783960708521023,0.0005029014123605413
NCT00432640,Assessment of Surgical sTaging vs Endoscopic Ultrasound in Lung Cancer: a Randomized Clinical Trial (ASTER Study),0.0004953366173154514,0.0006406261237852635
NCT00416689,Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer,0.0005926648379574364,0.0005539210438444578
NCT00404365,Depression Screening in Patients With Lung Cancer,0.000706170891885862,0.0005211565418095646
NCT00434174,Safety of Everolimus and Pemetrexed in Lung Cancer Patients,0.0007168499280006848,0.0009167607236376785
NCT00471978,DNA Analysis of Blood and Tissue From Patients With Lung Cancer,0.0006207800826383483,0.0006108893676785867
NCT00460551,Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer,0.0004680213313486011,0.0006085705145266213
NCT00489996,Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer,0.0006327750112545498,0.000849889652156958
NCT00489983,Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy,0.000621503794545438,0.0007127727811191591
NCT00482014,"A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer",0.0007897755796635874,0.0009174438054270265
NCT00482118,"Smoky Coal Exposure, Genetic Susceptibility, and Lung Cancer in Non-Smoking Women in China",0.00045323406158013715,0.0004625988575996911
NCT01886573,Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery,0.0005953802260382569,0.0008173813986362395
NCT01862081,"A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung Cancer",0.0007645897919196185,0.0007342738803479988
NCT01862770,Effect of Lung Cancer Diagnoses on Family Behaviors,0.0005177477399340112,0.0005821417006310822
NCT01888510,CT in Diagnosing Patients With Lung Cancer,0.0008957724102054762,0.0008264323365059683
NCT01888601,TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx),0.0009470300251387546,0.0007871657377431664
NCT01893580,Perioperative Rehabilitation in Operation for Lung Cancer,0.0006531101185990847,0.0006618187154814098
NCT01877811,"Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors",0.000677817800875276,0.0006239927725961538
NCT01877902,Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System,0.0006393741188165703,0.0007164262572999255
NCT01852838,The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung Cancer,0.0006215298277402994,0.0005120964372208033
NCT01874678,A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer,0.0007729129896827811,0.0007185903846648425
NCT01899989,Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer,0.0008918144552675963,0.0007113019597971359
NCT01828099,LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer,0.0008127117385576041,0.0009351721333050012
NCT01853826,An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s),0.0008064585935231913,0.0007519704204878195
NCT01883986,Supportive Care for Patients Newly Diagnosed With Lung Cancer,0.0007157386574462363,0.0004933084253483052
NCT01836575,Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2,0.0006276182031009969,0.0007918874022004682
NCT01836679,Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer,0.0006382885007656154,0.0008327233388537331
NCT01836341,Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation,0.0005948631292070776,0.0007396047693286936
NCT01846520,"Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers",0.0005445239603674563,0.000555243503398104
NCT01855191,SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation,0.0007461769223704171,0.0006095621354528017
NCT01809210,Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer,0.0006179573523678837,0.00065474292589567
NCT01880528,Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer,0.0006468126239007533,0.0007104494388660273
NCT01861197,Phase II Study of Dovitinib for FGFR1 Amplified Squamous Non-small Cell Lung Cancer,0.0006976650631172854,0.001071423079047668
NCT01829113,Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer,0.0006046882796102244,0.000855336426209699
NCT01823094,CTP Imaging of Lung Cancer,0.0008874260700349478,0.00035903729736163617
NCT01865903,Nutritional Problems and Changes in Body Composition in Patients With Non-small Cell Lung Cancer (LEKS),0.0006852992197585337,0.00047819242420864245
NCT01820325,Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer,0.0007851185902728497,0.0007237583257086955
NCT01881906,Exercise in Advanced Stage Lung Cancer Patients,0.0007110160187529197,0.0005852812438576474
NCT01881516,Acupuncture Research on Lung Cancer Patients With Cancer Related Fatigue（CRF）,0.0006207525866814397,0.0006252320530522676
NCT01850303,MODEL (Maintenance Versus Observation After inDuction Chemotherapy in Non-progressing Elderly Patients With Advanced Non-small Cell Lung Cancer),0.0007416504122428722,0.0007181069575598677
NCT01859338,"MRI, Cone Beam CT, and Fan Beam CT in Detecting Soft Tissue in Patients With Prostate and Lung Cancer Undergoing Radiation Therapy",0.0005757072552516381,0.000606882760906434
NCT01822496,Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007122076792207182,0.0008834005643193086
NCT01871454,Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers,0.0005974180399672213,0.0005782212179096031
NCT01887769,Body Composition Analysis for Patient With Lung Cancer Using Computed Tomography Image Analysis,0.0006158218511473201,0.0005799166438373033
NCT01885754,Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer,0.0007066723316462981,0.0006431064996690188
NCT01837329,Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer,0.0006464969674143332,0.0007405737024403474
NCT01854684,Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery,0.0007373144646639465,0.0007483944265632012
NCT01898156,"Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer",0.0005332632503168949,0.000575498693555065
NCT01851161,Prone Patient Positioning in Reducing Tumor Motion and Improving Breathing Reproduction in Patients With Lung Cancer Undergoing Radiation Therapy,0.0005820401429163535,0.0006023811730713826
NCT01802021,Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients,0.0005687852425918541,0.0007051511168360785
NCT01969955,Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer,0.0005733032515677267,0.0008735458708940597
NCT01995188,A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer,0.0006249259235811143,0.0006504552446691146
NCT01980212,Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer,0.0006680347537393955,0.0007437166002244286
NCT01980849,Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer,0.0005869443753023205,0.0004767135492940023
NCT01980472,Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients,0.0008156544421526508,0.0010047143343559321
NCT01977209,Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression,0.0004754029690371968,0.0005716382500379392
NCT01937637,Improving Management of Breathlessness in Patients With Lung Cancer,0.0007076964931232765,0.0006229989163045641
NCT01950156,Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer,0.0006994720950661261,0.0006851646193368615
NCT01952860,Hatha Yoga in Lung Cancer Couples,0.0008778138091156761,0.000622843116488247
NCT01911507,INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung Cancer,0.0009092922735553863,0.0007750835357977515
NCT01911325,Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients,0.0008258286221849064,0.0007583522803428107
NCT01967095,Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer,0.0006047683774926494,0.0005928817923963015
NCT01909752,Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer,0.0007110718957639291,0.0007915692532596571
NCT01982955,Tepotinib With Gefitinib in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),0.0006423174229220702,0.0008071770187604581
NCT01924416,Lung Cancer Information Study (LCIS-R01),0.0006054771240693077,0.00041805823263207415
NCT01958931,Evaluate the Utility of the ProLung Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer,0.0004422318225950882,0.0007047859871013273
NCT01914120,the Quality of Life Assessment of Lung Cancer Patients in China,0.0008818744681116138,0.0007036527552228531
NCT01914458,Image Discovering Early Lung Cancer Project,0.0006249149024691232,0.0003682868396317925
NCT01918761,Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC),0.0007679631367665367,0.0007331498782230081
NCT01956331,Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer,0.00045659859306099203,0.0005288325089944163
NCT01963195,Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy,0.0006708223738670992,0.0008937873246210094
NCT01990261,A Study to Assess the Survival of Non-small Cell Lung Cancer Patients Treated With Tarceva After Failed Chemotherapy Treatment,0.0008081551745395203,0.0009008180258325962
NCT01968941,Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients,0.0005967050520871212,0.0005647562995099494
NCT01933828,Treatment of Early Stage Lung Cancer by VATS Versus OPEN Lobectomy,0.0005207590473823611,0.0005828842073317033
NCT01928836,Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China,0.0007167409312351733,0.0006847902545993096
NCT01930474,Analysis of Plasma Tumor DNA in Lung Cancer Patients,0.0007194930945664494,0.0006954502230680759
NCT01987232,"Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Subjects With Previously Untreated Extensive Stage Small-cell Lung Cancer",0.0005186628993064765,0.0007879113556823655
NCT01943578,Value of Physical Capacity Tests in Lung Cancer,0.0005149508392152871,0.0004255445267171634
NCT01998425,Circulating Fibrocytes in Non-small Cell Lung Cancer.,0.001276530102597968,0.0005803269268232743
NCT01998126,Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer,0.0005849693090880226,0.0006054539702626411
NCT01929200,Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation,0.0007118732190773905,0.0008522659626030089
NCT01993810,Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer,0.0007494481913669086,0.0008295384362228987
NCT01993550,Telephone Support Program for Lung Cancer Patients and Their Family Caregivers,0.0005710444369417312,0.0004013243670733337
NCT01991418,Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC),0.0006452278553012679,0.0006448925961773586
NCT01912625,"Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery",0.0007200867867398323,0.000903632570191767
NCT01955343,Immune Response in Lung Cancer,0.0006311884050874196,0.0006345639153351768
NCT01935336,Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers,0.0007069623069675313,0.0007209301180156905
NCT01935947,Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0007587354963974898,0.0007985633115541926
NCT01951586,Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer,0.0006314845276878112,0.0006541208835805051
NCT01951469,Gefitinib With or Without Pemetrexed/Cisplatin in Brain Metastases From Non-small Cell Lung Cancer,0.0005959714933213505,0.0005783862550499965
NCT01951755,Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC),0.0008361948656931491,0.0009049149653455674
NCT01951482,Pemetrexed/Cisplatin With or Without Bevacizumab in Brain Metastases From Non Squamous Non-small Cell Lung Cancer,0.0005992793814974634,0.0005721650938576487
NCT01925625,Early Cancer Detection Test - Lung Cancer Scotland,0.0006245558970191674,0.0004957441679494512
NCT01999673,Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer,0.0006505216291960983,0.0007229948490526157
NCT01999881,Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients,0.0006281471796771282,0.0005496372914942846
NCT01999985,Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC),0.0006494182337861595,0.0007440800038602351
NCT01999621,Determinants of Intensity of Care of Lung Cancer Patients With Organ Failure,0.0008822441763972787,0.0005050950995994542
NCT01949701,Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer,0.0006994720950661261,0.0006653584546217932
NCT01949181,"Blood, Hair and Lung Concentrations of Metals and Metalloids in Patients With Lung Cancer or Chronic Obstructive Pulmonary Disease",0.0005516707854388854,0.0007909694838939453
NCT01949259,Rapid Learning for Lung Cancer,0.0008761522936284458,0.0005741963695221944
NCT01941303,Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent Disease,0.0007297716581191731,0.0007479335519715606
NCT01931306,Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC),0.0008074378821481426,0.0008584211533009517
NCT01964157,"An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement",0.0007885028967768237,0.0007770198072090945
NCT01985113,Correlation Research of Thioredoxin Reductase in Lung Cancer,0.0008767059056802207,0.0005729499385008107
NCT01939210,Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation Therapy,0.0005601922190892086,0.0005598180189067425
NCT01938456,Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer,0.0005969161474369823,0.000710216637338144
NCT02630615,Circulating Tumor Cells (CTC) in Lung Cancer,0.0008805504052592629,0.0006253114532283972
NCT02619266,The Safety and Effect Study of Acupuncture for Anorexia in Patients With Gastrointestinal Tract and Lung Cancers,0.0006146581508258277,0.0006995774467304374
NCT02619448,Concurrent Chemotherapy and Accelerated Hypofractionated Radiation in Medically Inoperable Non-small Cell Lung Cancer,0.0006749489624630037,0.000760855564117395
NCT02696863,Plan for Systematic Identification of Lung Cancers of Occupational Origin: Implementation Study,0.0006071642563951783,0.0004547915613550081
NCT02696525,Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients,0.00060033813525664,0.0007501568589143087
NCT02686775,The PACO Project: A Clinical Study of a PAtient COach Program in Vulnerable Lung Cancer Patients,0.0006495072142938558,0.000671549042678637
NCT02665390,Percutaneous Cryoablation Peripheral Lung Cancer,0.0008767077981073676,0.0009615194688376276
NCT02612532,Lung Cancer Indicator Detection,0.0006285903064979941,0.0007101261843643846
NCT02644252,Tocotrienol as a Nutritional Supplement in Patients With Advanced Lung Cancer,0.0006250388301290783,0.0005649288995026179
NCT02688686,Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases,0.0008460507611039542,0.0007779699348262709
NCT02693080,CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy,0.0007235787897684789,0.0007760473055992949
NCT02608411,TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES),0.0006792515462149882,0.0008999848626830067
NCT02664792,Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer,0.0005180183659794025,0.0004078595514237022
NCT02638090,Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC),0.0007515142272881202,0.0006924676128251702
NCT02655536,"Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial",0.0005422644253632472,0.0006860319887665224
NCT02671045,Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer,0.0006418171917716304,0.0006031020374181801
NCT02663492,Transcutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer Patients,0.0007797349543031796,0.0007013904241124969
NCT02642042,Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer,0.000705888247189225,0.0008361980720172102
NCT02613637,Registry Study on Biological Disease Profile and Clinical Outcome in Patients With Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-Project,0.0006132534986028388,0.0007538089513270784
NCT02666755,Novel Detection System for Lung Cancer Curative Effect Monitoring,0.0006304540827313859,0.0007228417883390861
NCT02679963,Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer,0.0007374849328830852,0.0007764023267933798
NCT02603627,"Prevalence of COPD in Our Lung Cancer Population, Compared to Controls",0.0016733468092925384,0.0009459535013189527
NCT02603367,COMFORT Caregiver Intervention in Improving Communication and Reducing Distress in Caregivers of Patients With Lung Cancer,0.0006184891802356134,0.0005020683401923178
NCT02629523,Afatinib in Lung Cancer With EGFR Mutation From Circulating Tumor DNA,0.0006433836203930809,0.0008895884781285038
NCT02629458,A Study to Determine the Feasibility and Acceptability of Conducting a Phase III Randomised Controlled Trial Comparing Stereotactic Ablative Radiotherapy With Surgery in paTients With Peripheral Stage I nOn-small Cell Lung Cancer cOnsidered Higher Risk of Complications From Surgical Resection,0.0006633512919853758,0.0008086901060830774
NCT02691299,A Phase III Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer,0.0007729718746418562,0.0006617567111301609
NCT02695550,"Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer",0.0007947769796456032,0.0008973444001270065
NCT02675842,Investigation of Cannabis for Pain and Inflammation in Lung Cancer,0.00046103159812658703,0.0005637972809121699
NCT02607423,Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery,0.0007360832835983977,0.0008143581102054655
NCT02676050,Visualising c-MET and Activated Neutrophils in Lung Cancer,0.0008761522936284458,0.0004584512860480313
NCT02617186,Robotic Lobectomy vs. Thoracoscopic Lobectomy for Early Stage Lung Cancer,0.000547631920678451,0.00042473475087650823
NCT02699229,Non-linear Multimodal Microendoscopy for Lung Cancer Pathology,0.000621166269048323,0.0004948302568191319
NCT02699606,"A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma",0.0006600155037845071,0.000686849559607446
NCT02681549,Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer,0.0005898005780746657,0.0007577341297855769
NCT02673814,Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer,0.0006374352892094941,0.0007216169350098696
NCT02658032,Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP),0.0006576099972800094,0.0005811473562084749
